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The aim of the study was to determine the factors that influence adherence to ART 
among adolescents who contracted HIV through vertical transmission. Qualitative 
research using descriptive phenomenology was conducted at Botswana-Baylor 
Children’s Clinical Centre of Excellence. 
 
Data was collected using in-depth individual semi-structured interviews. Eight (8) 
adolescents between 14 and 19 years who had been on ART for minimum of 4 
years were interviewed. Thematic analysis of data was done and five (5) themes 
emerged from the participants' description of the experience of taking ART taking 
ART over a long period of time. The themes that emerged indicated the factors 
that influence adherence to ART, and they included knowledge and positive beliefs 
about ART, need for support, ART difficult treatment regimen, having a regular 
doctor and psychosocial emotional needs. 
 
The findings suggested that the adolescents who contracted HIV through vertical 
transmission require support while continuing on a simplified long-term ART 
regimen after an assessment of their psychological well beings and periodic 
checks. 
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ORIENTATION TO THE STUDY 
 
1.1 INTRODUCTION 
The treatment of the human immunodeficiency virus (HIV) by antiretroviral therapy 
(ART) has prolonged the lives of many people living with HIV including the lives of 
a special group of people, the adolescents who contracted HIV through vertical 
transmission. These are the adolescents who were born HIV positive because the 
virus was transmitted to them from their HIV positive mothers during pregnancy, 
birth or breastfeeding. The adolescents who contracted HIV through vertical 
transmission start ART at a very young age and have to be on treatment for a long 
time. When they are still very young, they are supervised to take their medicines 
but as they grow older and reach adolescence and adulthood, they may have to 
take their medicines on their own (Naar-King, Parsons, Murphy, Chen, Harris & 
Belzer 2009:1092). 
 
Antiretroviral therapy is administered in the form of highly active antiretroviral 
therapy (HAART), which is a combination of at least three different class drugs to 
suppress the HIV and stop the progression of HIV disease. In order to achieve the 
benefits of HAART, high levels of adherence to the ART are required (Ding, 
Wilson, Modjarrad, McGwin, Tang & Vermund 2009:1101). Non-adherence to ART 
may result not only in reduced treatment efficacy but also in the development of 
viral resistance and increased progression to AIDS (Protopopescu, Raffi, Roux, 
Reynes, Dellamonica, Spire, Leport &Carrieri 2009:599).  
 
Adherence to long-term ART is a challenge to adolescents because, according to 
Protopopescu et al (2009:600), they experience pill burden and fatigue. Other 
challenges associated with adherence to ART in adolescents include decreased 
parental support, increased autonomy, stigma, difficulty in identifying with HIV-
negative peers, anxiety about sexual relationships and future planning, low self-




Nichols, Kammerer, Siros, Farley & Marley 2006:1746).  
 
1.2   BACKGROUND TO THE RESEARCH PROBLEM 
In 2009 there were 33.3 million people worldwide living with HIV and AIDS 
(UNAIDS 2010:23), 2.5 million of whom were children. The majority (22.5 million) 
of those people living with HIV lived in sub-Saharan Africa.  
 
Botswana is one of the countries with the highest HIV prevalence in sub-Saharan 
Africa (UNAIDS 2010) with an estimated HIV prevalence of 24.8% of adults 15 – 
49 years of age. According to UNAIDS, the percentage of pregnant  women who 
were HIV positive was 33% in 2005 and about a third of babies born to HIV 
positive mothers would contract HIV through vertical transmission in the absence 
of any interventions  (UNAIDS 2010). 
 
Botswana implemented a successful prevention of mother to child transmission 
(PMTCT) programme which was the first to distribute free ART to HIV positive 
people. As a result of the PMTCT programme, the percentage of pregnant women 
who were HIV positive fell from 38.6 % in 2003 to 24.3 % in 2009. Again, 
according to the USAID (2010) the proportion of babies born to HIV-positive 
mothers who were infected decreased from 20.7% in 2003 to less than 4% in 
2009.  
 
Prior to the rollout of the PMTCT programme, many children born to HIV-positive 
mothers contracted HIV through the vertical transmission. Because of the free 
ART, the HIV positive children were afforded the opportunity to live longer and 
healthy lives. As the provision of ART in national programs scale up, more HIV 
positive adolescents lived longer and reached adolescence and adulthood.  
 
1.3 THE RESEARCH PROBLEM 
The Botswana-Baylor Children’s Clinical Centre of Excellence (BBCCCOE) also 




for HIV positive children and adolescents. There are 618 adolescents (10-19 
years) on ART attending clinic and the average age of clients at the clinic is 9 
years according to the 2009 annual report. There are more than 2000 children on 
treatment at the centre. Adherence to ART among some of the adolescents is a 
major challenge. According the clinic’s monitoring and evaluation report, 6% of the 
total clients at the clinic failed treatment (detectable viral load of above 400 
copies/ml) between July 1, 2008 and June 30, 2009 (BBCCCOE 2009:9). These 
clients fail treatment mainly because of poor adherence to the ART regimen. At 
any given time 45 % of them will have adherence to ART which is not acceptable. 
 
Even though the effective adherence levels to ART have not been fully defined, 
the levels of adherence below 90-95% have been associated with poor response 
to treatment (Reisner, Mimiaga, Skeer, Perkovich, Johnson & Safren 2009:14). 
Poor adherence to ART among adolescents attending the BBCCCOE is of great 
concern because, where adherence levels are sub-optimal, the HIV may rapidly 
become resistant to therapy and progression to AIDS may be increased 
(Protopopescu et al 2009:599), hence the focus on adherence to ART among 
adolescents attending the BBCCCOE in this study. 
 
1.4 THE AIM OF THE STUDY 
The aim of the study was to determine the factors that influence adherence to ART 
among adolescents who contracted HIV through vertical transmission, attending 
the BBCCCOE. 
 
1.4.1 Research purpose 
The purpose of the study was to describe the factors influencing adherence to 
ART among adolescents at the BBCCCOE in order to target adherence 
interventions in Botswana. 
 
1.4.2 Research objectives 




the following questions: 
 What are the factors influencing adherence to ART among adolescents at 
the BBCCCOE? 
 What supportive interventions can be implemented to promote adherence 
to ART among adolescents at the BBCCCOE? 
1.5 SIGNIFICANCE OF THE STUDY 
The study sought to describe the factors influencing adherence to ART among 
adolescents at the BBCCCOE. The knowledge of such factors would assist in 
ensuring that programmes for adolescents include specific measures to improve 
adherence to ART treatment in Botswana. The health care workers would be in a 
better position to deal with adolescents once they understand the factors that 
promote or hinder adherence to ART.  
 
Research on adherence to ART in HIV positive adolescents (who contracted HIV 
through vertical transmission) in Botswana is limited. Many studies on adherence 
to ART were done in adults and very few studies have examined adherence 
among HIV positive adolescents (Murphy, Wilson, Durako, Muenz &  Belzer 2005; 
Murphy, Sarr, Durako, Moscicki, Wilson & Muenz 2003). In one of the few studies 
done on ART adherence in young people, it was found that only 50% of the 
American HIV positive adolescents reported taking their prescribed ART all the 
time (Murphy, Wilson, Durako, Muenz &  Belzer 2001:34).  The findings of the 
study would increase the body of knowledge on factors associated with adherence 
to antiretroviral therapy by adolescents in Botswana. 
 
1.6 DEFINITION OF TERMS 
The following outlines the definitions of key concepts used in this study; 
 
Adherence  
According to the Pocket Oxford English Dictionary (2005), adherence means “to 
stick fast to substance, person, party, and opinion”. Adherence to treatment is 




treatment under limited supervision when faced with conflicting demands, as 
distinguished from compliance and maintenance (Medical-dictionary online). ART 
should be taken 100% of the time for it to be effective.  Adherence can also be 
measured subjectively using patient reports or objectively using pill counts.  
 
For the purposes of the study, adherence refers to the extent to which 
adolescents’ behaviour of taking  ART corresponds with agreed recommendations 
from a health care provider (the doctors’ prescription and health advice from 
nurses and health educators) meaning that ART is taken 100% of the time (every 
day as prescribed, not missing any dose of ART). Adherence can also be 
measured subjectively using patient reports or objectively using pill counts. In this 
study adherence would also be measured by means of calculations from pill 
counts (Paterson, Swindells, Mohr, Brester, Vergis, Squier, Wagner & Singh 
2000:22) which are done every time a client comes to the clinic for follow up or for 
refill of their medicines. 
 
Acceptable (good) adherence in this study was that between 95 and 100% while 
poor (unacceptable) adherence was anything below or above this range. 
Adherence above 100% may mean that a client took an overdose, repeated a 
dose such as after vomiting and this is also unacceptable adherence. Acceptable 
adherence was synonymous with good adherence while unacceptable adherence 
was synonymous with poor adherence to ART. 
 
ART means the antiretroviral drugs used a combination of at least two different 
class drugs to suppress the HIV and stop the progression of HIV disease 
(Bendavid, Grant, Talbot, Owens & Zolopa 2011:211). ART was used in this study 
to refer to the drugs that the adolescents are taking, prescribed in drug 
combinations referred to as highly active antiretroviral therapy (HAART). 
 
An adolescent is defined by WHO (World Health Organization) as an individual in 




WHO as a child between 10 and 19 years of age who contracted HIV through 
vertical transmission.  
A factor is defined by the Pocket Oxford Dictionary (2005) as “one of the elements 
contributing to a particular result or situation”. In this study these elements 
(factors) contributing to acceptable or unacceptable adherence to ART are 
described. 
 
HIV positive: A person is said to be HIV-positive when antibodies against HIV 
have been detected on a blood test or gingival exudates test (commonly known as 
a saliva test). Synonym: seropositive (UNAIDS 2011). 
 
Influencing is defined as “the capacity or power of persons to be a compelling 
force on or produce effects on the actions, behaviour or opinions” (Webster’s 
Unabridged Dictionary of the English Language 2001). In this study, the same 
definition applies.  
 
Vertical transmission of HIV is the transmission of HIV from an infected pregnant 
woman to her newborn child. Transmission can occur at any time during 
pregnancy, delivery or breastfeeding (De Cock, Fowler, Mercier, de Vincenzi, 
Saba, Hoff, Alnwick, Rogers and Shaffer 2000:1175) The same definition applied 
in this study. 
 
1.7 META-THEORETICAL ASSUMPTIONS 
Assumptions refer to basic principles that are accepted as being true based on 
logic or reason without proof (Polit & Beck 2006:495). It was assumed in this study 
that:  
 The experience of adolescents who are HIV positive and taking ART 
would put them in a position to give insight into what makes one to 




 The critical truth can be found through in-depth individual semi-
structured interviews about the factors that influence adherence to ART.  
 The participants would be honest in their responses to the interview 
questions.  
 
1.8. RESEARCH DESIGN AND METHODS 
This study is non-experimental and qualitative in nature with a descriptive 
phenomenology approach. Qualitative approach was used to develop a rich 
understanding of the phenomenon adherence to ART among adolescents as it 
exists in the real world and as it is constructed by individuals within the context of 
that world (Polit & Beck 2006:212). Phenomenology attempts to understand 
people’s perceptions, perspectives and understanding of a particular situation (de 
Vos 2005:264). 
 
The study population for the study comprised of HIV positive adolescents on ART 
attending the BBCCCOE. The adolescents had to meet the following inclusion 
criteria:  
 Male and female adolescents aged  between 10 and 19 years  
 They must have been taking ART for at least 1 year. 
 They must have contracted HIV through vertical transmission 
 Signed informed consent by parent or caregiver. Adolescents in this study also 
had to sign an assent form. The age of consent in Botswana is 21(Botswana 
2010:8). 
 
A non-probability sampling purposive method was used to select study 
participants. The clinic has a record of adolescents who contracted HIV through 
vertical transmission on ART. Convenience sampling was also used to select the 
adolescents who were available and met the eligibility criteria. Adolescents with 
poor adherence and those with good adherence were included in the study and 




documents adherence at every visit. Those with poor adherence were also found 
in the treatment failure group. The sample size was not specified, the principle of 
saturation of data was adhered to.  
 
Data was collected by means of in-depth individual semi-structured interviews and 
the interviews were audio recorded. Data on adherence to ART was collected from 
the electronic medical records system and was based on pill counts (proportion of 
what the client took against what client was expected to take). This was used to 
select the two groups of participants (compliant and non-compliant ones) in line 
with the inclusion criteria.  
  
Data analysis for this study was thematic analysis according to Van Manen (1990) 
cited in Polit and Beck (2008: 519) using the holistic and the selective approaches. 
According to Van Manen, thematic aspects of experience can be uncovered or 
isolated from the participant’s description of the experience. 
 
The tape recorded interviews were first transcribed verbatim into text as Microsoft 
word document. The researcher read through each transcript to familiarise self 
with the data, get a sense of the whole and to search for meaningful segments or 
units. The researcher also listened to audio recordings of each transcript in order 
to verify the transcriptions. While reading the transcripts, the researcher made 
notes of any thoughts, observations and reflections that occurred. The notes 
comprised of recurring phrases, words or group of words with similar meaning or 
connotations. 
 
The researcher then identified themes from within each section of the transcript. 
The final step involved weaving the thematic pieces together into an integrated 
whole to provide an overall structure to the data. The themes were clustered into 






1.9 SCOPE AND LIMITATIONS OF THE STUDY 
A qualitative study was done to allow in-depth understanding of the factors 
affecting adherence at the BBCCCOE. The adolescents who participated  in this 
study  attend the referral centre may allow for rich data regarding factors affecting 
adherence but this may not represent the same status quo in other facilities in 
Botswana.  
 
Adherence in this study was extracted from the electronic medical record system 
and was calculated based on pill counts only and not based on virologic 
suppression. The implication is that some informants with good adherence may 
not have viral suppression even though categorised as being good with adherence 
to ART. Some patients with calculated acceptable adherence had detectable viral 
load indicating poor adherence or drug resistance. A perfect pill count with no viral 
suppression may also indicate pill manipulation. 
 
1.10 STRUCTURE OF THE DISSERTATION  
Chapter 1: This chapter will give an overview and will serve as an introduction to 
the study. It will also give the background as the chapter gives an orientation of the 
study. 
 
Chapter 2: The literature review 
 
Chapter 3: This chapter will cover the research design, the research methodology 
as well as giving aspects of internal and external validity of the study. 
 
Chapter 4: Data analysis, the research results and literature control. 
 








The background of the study, research questions and the research design has 
been introduced as well as the reflections on the significance of the study. The 
research design is meant to ensure both rigour and trustworthiness. The sampling 
methods, data collection techniques and the data analysis procedures were 














































This chapter presents relevant literature pertaining to adherence to antiretroviral 
therapy (ART) in adolescents who contracted HIV through vertical transmission.   
A literature review is defined by Polit and Beck (2006:503) as a critical summary of 
research on a topic of interest, in this instance the factors influencing adherence to 
ART among adolescents at Botswana–Baylor Children’s Clinical Centre of 
Excellence (BBCCCOE). The aim of the review was to enable the researcher to 
gain insight into the problem under scrutiny, verify the significance of the problem, 
put the research problem in context and to determine the most appropriate 
methodology, including the research instrument (Burns & Grove 2007:93).  
 
2.2 PURPOSE OF THE LITERATURE REVIEW 
The purpose of a literature review is to convey to the reader current knowledge on 
the subject at hand (Burns & Grove 2007:93). A literature review is critical in order 
to: 
• identify a research problem and refines research questions. 
• know what is already known about the research topic. 
• identify the gaps in the literature. 
• identify new clinical interventions to be tested during research. 
• help identify appropriate research designs and data collection methods for 
the study. 
• get insights for interpretation of study findings and implications of the study 
      (Polit & Beck 2006:133). 
 
Literature review was done in this study to determine the factors that influence 







2.3 SCOPE OF THE LITERATURE REVIEW 
A literature review in this study focused on HIV and ART as well as the 
relationship between response to treatment and adherence. The existing literature 
on adherence to ART among HIV positive adolescents was reviewed. The 
researcher reviewed various research reports, statistics and studies conducted 
globally including the country of the study, Botswana. The key concepts used for 
the literature review study were antiretroviral therapy, adherence to ART, factors 
influencing adherence to ART and challenges facing adolescents living with HIV 
regarding ART and adherence among adolescents. The key concepts were used 
as topics to discuss the literature reviewed.  
 
2.4 LITERATURE REVIEW 
 
2.4.1 Antiretroviral therapy (ART) 
Anti-retroviral therapy (ART) refers to the use of pharmacological agents that have 
inhibitory effects on HIV replication.  ART consists of a combination of at least 
three antiretroviral (ARV) drugs to maximally suppress the HIV virus and stop the 
progression of HIV disease. If ART is taken reliably and correctly, the drugs can 
reduce the virus to a level in the blood when it can no longer be measured 
(undetectable), restore the immune system, prevent HIV transmission, reduce 
HIV-related morbidity and mortality and improve the quality of life  
(http://www.who.int/hiv/topics/arv/en).   
 
ART is lifelong treatment which requires that the right doses of the right drugs 
must be taken at the right time. It is not a cure but it turns HIV and AIDS from 
being a fatal condition to a chronic one, manageable with medication. ART 
improves the quality of life of people living with HIV and AIDS (PLWHA), as they 
prevent the onset of opportunistic infections.  
 
 A dramatic reduction in HIV-related morbidity and mortality has been recognized 
in countries where ART has been widely available. Again expanded access to 




preserve families (WHO 2010). This is supported by evidence in a meta-analysis 
of the association between adherence to drug therapy and mortality (Simpson, 
Eurich, Majumdar, Padwal, Tsuyuki, Varney & Johnson 2006:15; Judd, Doerholt, 
Tookey, Sharland, Riordan, Menson, Novelli, Lyall, Masters, Trudor-Williams, 
Duong & Gibb 2007:918).  
 
According to WHO (2010) progress report on global HIV/AIDS response, 
Botswana is one of the countries of the region with generalised epidemics that has 
achieved universal access to ART, providing it to at least 80% of patients in need.  
As a result of access to ART in Botswana, HIV related mortality shows a 
remarkable decrease and prolongation of the duration and quality of survival in 
HIV positive people.  
 
Children who acquire HIV from birth should start their ART treatment as soon as 
the HIV diagnosis is established which is often at just a few months old 
(http://www.aidsinfo.nih.gov/ContentFiles/Adultand adolescentGL.pdf).  If they are   
supported to adhere to medication, more HIV positive children survive into 
adolescence on chronic therapy.   
 
Botswana has a national programme which offers ART for free for both 
prophylaxis and treatment. As of December 2010 the Botswana’s public health 
system had 161 219 patients on ART and of this, 6.6% were children (Department 
of HIV/AIDS prevention and care, 2010). The total number of children and 
adolescents represents 80% of those in need of therapy according to the 
department of HIV/AIDS prevention and care, Botswana. The mortality rates have 
reduced as a result of ART access in Botswana. 
  
Mortality trends in the US perinatal AIDS collaborative transmission study showed 
that there was a remarkable decrease in mortality and prolongation of survival in 
perinatally infected children (Kapogiannis, Soe, Nesheim, Abrams, Carter, Farley, 




access to ART. The implication is that these perinatally HIV infected children will 
have to be on ART for a long time and adherence to chronic medications becomes 
very important.  
 
2.4.2 Importance of adherence to ART in HIV management 
Adherence is critical in any treatment and it refers to the extent to which a person’s 
behaviour, in terms of taking medications coincides with the prescribed treatment 
regimen and the advice given by health care providers (Osterberg & Blaschke 
2005:487). Full benefit of medication can only be realized if patients follow 
prescribed treatment regimens and this is more important with HIV treatment 
where there is a risk of development of resistance with poor adherence.  
 
Behaviours associated with adherence to ART such as taking doses at the same 
time every day, following food restrictions and not skipping doses as a result of 
irregularities in routines remain a challenge especially for young people living with 
HIV infection (Reisner et al 2009:14). High levels of adherence to ART (at least 
95%) are needed to ensure optimal benefits of ART. 
  
Though effective adherence levels have not been fully defined for ART, levels of 
adherence below 95% have been associated with poor response to treatment 
(Paterson et al 2000). Maintaining high levels of adherence remains a critical 
element of modern HIV care. Non-adherence to ART may result not only in 
reduced treatment efficacy but also in the development of viral resistance and 
increased progression to AIDS (Protopopescu et al 2009:599). 
 
Adherence to ART can be measured in a variety of ways. Miler and Hays (2000) 
identified the following as approaches to measure adherence in patients on ART; 
patient self-reported adherence, clinician-estimated adherence, pill counts, patient 
diaries, clinic attendance, pharmacy records, plasma levels, surrogate or indirect 
laboratory markers and electronic monitors. Self-reported adherence is a simple 




medication in an interview or in some cases by means of a survey. Patient self-
reported adherence overestimates adherence by as much as 20 % but a self-
report of non-adherence is a strong indicator and should therefore be taken 
seriously (Arnsten, Demas, Farzadegan, Grant, Gourevitch, Chang, Buono, 
Eckholdt, Howard & Schoenbaum 2001:1417). 
 
An undetectable viral load and greater CD4 counts of greater than or equal to 
500cells/µL are associated with acceptable adherence while a detectable viral load 
and later disease are associated with non-adherence (Murphy et al 2003:253; 
Murphy et al 2005:778; Murphy et al 2001:38; Williams et al 2006:e1749; Schwarz, 
Henry-Reid, Houser, & Ma 2001:120). The goal of treatment of reducing the viral 
load and increasing the CD4 count is actually protective for adherence. The 
relationship between these markers (CD4 and viral load) demonstrates a cycle 
which exists. 
 
In a study on adherence to ART among HIV positive American adolescents, the 
results showed that only 41% reported taking all the prescribed treatment (Murphy 
et al 2001:27).  Such low levels of adherence can easily lead to the development 
of viral resistance. Other studies done on adherence and intervention among HIV-
infected in the United States on HIV and AIDS, found that youth overall rates of 
adherence in the 30 days prior to study enrolment ranged between 28.3% to 
69.8% (Reisner et al 2009:15).  
 
Implications of poor adherence include virologic failure and eventual resistance 
and deterioration of the clinical condition. Immunologic failure is also associated 
with poor adherence and these implications were demonstrated in a study in South 
Africa which showed that a cumulative adherence of <95% to drug-refill visits was 
significantly associated with both virologic and immunologic failure (El-Khatib, 
Katzenstein, Marrone, Laher, Mohapi, Petzold, Morris & Ekstrom 2011:3). El-
Khatib et al (2011) investigated adherence to drug-refill as a useful early warning 




ART in South Africa and recommended drug-refill monitoring as one of the many 
adherence tools.   
 
Pilot ARV treatment programmes in Cambodia, South Africa, and Uganda have 
achieved short-term adherence rates of about 90%, largely among adult patients 
(Oguda 2004). In a review of studies done in the United States on HIV ART 
adherence and intervention among HIV-infected youth overall rates of adherence 
in the 30 days prior to study enrolment ranged from 28.3% to 69.8% (Reisner et al 
2009:15). These studies show the variation of adherence which is also 
geographical with adherence being higher in Cambodia, South Africa and Uganda. 
The implications would be that factors affecting adherence would be different in 
these geographical locations. 
 
In an article on youth with HIV and AIDS certain developmental characteristics of 
adolescents such as their sense of invulnerability and difficulty in deferring 
gratification may present obstacles to acceptance of an HIV diagnosis, adherence 
to treatment, and use of HIV prevention measures (Botwinick, Bell, Johnson, Sell, 
Friedman, Dodds, Shaw, Martinez, Sicilliano, Walker & Sotheran 2003:50). This is 
among the many factors that have been implicated as affecting adherence in the 
youth and the implications thereof. Other factors include disclosure, stigma, 
physical development and sexuality (Ding et al 2009:1100). 
 
In Botswana adherence studies in adolescents living with HIV are limited. Phalade, 
Nthomang, Ngwenya and Seboni (2009) investigated challenges faced by 
adolescents living with HIV in Botswana and found that stigma, discrimination, HIV 
disclosure are associated with adherence. 
 
2.4.3 Factors influencing adherence to ART 
There are many factors that are associated with adherence in HIV-positive 
adolescents. In a paper presented at the AIDS Impact conference in 2009, 




adherence to ART among adolescents living with HIV and AIDS (Phalade et al 
2009). These researchers used a qualitative approach with focus groups and in-
depth interviews and found that adherence to ART is a major problem for 
adolescents mainly because of stigma, discrimination, HIV disclosure as well as 
interference with school activities. This study was conducted in Botswana. The 
following categorizes some of the generic factors that influence adherence with 
highlights of those affecting adolescents; 
 
2.4.3.1 Demographic factors 
Demographic factors such as age and gender described in literature have been 
inconsistent in predicting adherence in adolescents. Murphy et al (2005:768) found 
that the younger age group was associated with poorer adherence while in other 
studies there was found no association either adherence or non-adherence 
(Murphy et al 2001:35; Comulada, Swendeman, Rotheram-Borus, Mattes & Weiss 
2003:392). Williams et al (2006:e1748) in their study on predictors of adherence to 
ART in children and adolescents with HIV infection found the worst adherence to 
be in the older adolescents aged 15 to 18 years. 
 
Gender has not been shown to be a major demographic factor that influences 
adherence. Williams et al (2006:e1749) found that female subjects and those 
without English as their primary language had marginally significant increases in 
the odds of non-adherence.   
 
School attendance was associated with better adherence in a longitudinal ART 
adherence study in adolescents living with HIV while unstable household as 
associated with poorer adherence (Murphy et al, 2005:35; Martinez, Bell, 
Camacho, Henry-Reid, Watson & Rodriguez, 2000:57). It is important to recognise 








2.4.3.2 Psychosocial factors 
Several studies identified a number of psychosocial factors associated with poor 
adherence and non-adherence to ART including HIV stigma, discrimination by 
friends and family members, depression, nondisclosure of HIV status, low levels of 
literacy, impact of long-term treatment on lifestyle  as well as interference with 
school activities (Ayres, Paiva, Franca, Gravato, Lacerda, Negra, Marques, 
Galano, Lecussan, Segurado and Silva 2006:1004 ; Biadgilign, Deribew, Amberbir 
& Deribe 2008:55; Do, Phiri, Bussmann, Gaolathe, Marlink & Wester 2010:685; 
Phalade et al 2009;  Reisner et al 2009:14). 
 
In-depth interviews with HIV positive adolescents and their caregivers at various 
AIDS treatment centres in Sao Paulo, Brazil identified stigma and discrimination as 
the most important challenges for people living with HIV. The stigma was 
characterized by subjective feelings of embarrassment associated with social 
discrimination which affected the young people’s identity. In Botswana, Phalade et 
al (2009) investigated challenges faced by adolescents living with HIV in Botswana 
and found that stigma, discrimination, HIV disclosure are associated with 
adherence. 
 
HIV disclosure is expected to eventually improve adherence, this was found to be 
true in a study conducted in Botswana on adolescents’ adherence to ART. Non-
disclosure of HIV status was associated with poor adherence to ART (Phalade et 
al 2009). Similar findings were shown in other studies by Ayres et al (2006:1004),  
Dodds, Blakley, Lizzotte, Friedman, Shaw, Martinez, Siciliano, Walker, Sotheran, 
Sell, Botwinick, Johnson and Bell (2003:39) and  Biadgilign, Deribew, Amberbir, 
Escudero and Deribe (2011:1757). 
 
In Ethiopia factors associated with HIV/AIDS diagnostic disclosure to children 
living with HIV receiving HAART were investigated and the finding was that the 




included strengthening the referral linkage and health education tailored to 
educated caregivers to increase the rate of disclosure (Biadgilign et al 
2011:17572). 
 
In a literature review of HIV antiretroviral adherence and intervention studies 
among HIV-infected youth aged between 13 and 24 years, psychosocial factors 
especially depression and anxiety were consistently associated with poor 
adherence across studies (Reisner et al  2009:14).  
 
In a study on psychosocial factors affecting medication adherence among HIV-1 
infected adults receiving combination antiretroviral therapy in Botswana, the 
researchers found that alcohol use, depression and nondisclosure of status to 
partner were associated with poor adherence rates (Do et al  2010:685). Even 
though this study was not in adolescents, these factors may also be found in 
adolescents. 
 
It would be assumed that social support system for an adolescent would promote 
adherence to ART. Surprisingly, in a review of literature on HIV antiretroviral 
adherence and intervention studies among HIV-positive youth conducted by 
Reisner et al (2009:15), there was no association was found between social 
support and adherence to ART. Stigma and discrimination by friends and family 
members were strongly associated with non-adherence to ART. However lack of 
family and social support was listed as one of the adherence concerns in 
adolescents (http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf) 
 
One interesting finding from a past study is the association of adherence with 
presence of a biological parent as opposed to any type of a caregiver (Williams et 
al, 2006:e1752). The researchers found that having an adult other than the 
biological parent as the primary caregiver (e.g. relative or other adult) and higher 
caregiver education level. There are many orphaned children as a result of the 




being present, it is not protective. The presence of a just another adult caregiver 
who is not the biological parent seems to be protective for non-adherence 
(Williams et al 2006:e1752). 
 
Social support, stigma and discrimination are important factors to be assessed 
during adherence counselling because of the implications they have on ART 
adherence. This is particularly important in adolescents especially where HIV 
disclosure has not occurred or disclosure has occurred but only within family 
members yet the adolescent still has to interact with friends in school or in the 
general community. 
 
2.4.3.3 Medication related factors  
 
Medication related factors such as inconvenient dosing frequency, complex 
regimens, difficulty taking medications, dietary restrictions, pill burden, lack of 
belief in the effectiveness of medication and side effects of ART affect adherence 
(Chesney  2000:S171). A low pill burden was associated with improved adherence 
while both physical and psychological medication-related adverse effects were 
associated with poor adherence (Murphy et al 2003:253; Murphy et al 2001:36). 
These studies also showed that the longer the duration of taking ART the poorer 
the adherence. Long duration of therapy was associated with pill fatigue especially 
in the perinatally infected adolescents who may have started treatment early on in 
life (Ayres et al 2004:1001; Chesney 2000:S172, Ding et al 2009:1104). Other 
factors related to medication that may affect adherence include the type of drug, 
and a poor doctor-health-care provider relationship.  
 
2.4.3.4 Adherence tools 
The use of reminder tools such as alarm clocks and pill boxes have been identified 
as some of the important factors that promote adherence to ART. In a study on pill 
boxes as adherence tools, Peterson et al (2007) estimated that pill boxes 
improved adherence by 4.1% to 4.5% and they were associated with a decrease 




The use of pill boxes is fairly inexpensive and Peterson et al (2007) recommended 
the pill boxes to be a standard intervention to improving adherence to antiretroviral 
therapy. 
 
The use of alarm clocks has always been known to be important as adherence 
tools that aid adherence to ART. A study done during the early stages of the HIV 
epidemic reported the use of alarm clocks to be effective. Mannheimer, Hirsh and 
El-Sadr (1998) conducted a study on the impact of an alarm device on ART 
adherence among patients in Harlem, USA. In the same study, Mannheimer et al 
found that patients were enthusiastic about the alarm device and after 3 months of 
using the device, 98% of the patients had 100% adherence levels.   
 
Wise and Operario (2008) noted that there was patient satisfaction across studies 
that examined the use of electronic reminder devices to improve adherence to 
ART but there was conflicting evidence of improved virological and immunological 
outcomes in some studies. The conclusion from this review was that there was 
lack of definitive data resulting in insufficient evidence about the effectiveness of 
electronic reminder devices as strategies for improving adherence to ART. 
 
In another qualitative study on understanding the facilitators and barriers of 
antiretroviral adherence, researchers found facilitators of adherence to include 
positive beliefs about medication as well as use of reminder tools which was 
reported in 58% of the participants (Curioso et al 2010:4). In this study one 
participant reported to be having a brain alarm which would buzz at the right time 
while others used alarm clocks. 
 
In a marginal structural model analysis study on pillboxes as adherence tools, 
Peterson, Wang, van der Laan, Guzman, Riley and Bangsberg (2007) estimated 
that pill boxes improved adherence by 4.1% to 4.5% and was associated with a 
decrease of viral load of 0.34-0.37 log10 copies/ml and a probability of viral 




recommending the pill boxes to be a standard intervention to improving adherence 
to antiretroviral therapy. 
 
2.4.3.5 Health care providers and the clinical setting 
There was one interesting study done by Radcliffe, Tanney and Rudy (2006:111) 
on post-traumatic stress and adherence to medical treatment among youth with 
HIV which showed that maintaining regular follow-up care and treatment with a 
specific provider was associated with increased adherence. Having a consistent 
medical provider emerged as an adherence promoting strategy. In a qualitative 
study on understanding the facilitators and barriers of antiretroviral adherence in 
Peru, a relationship with a specific medical provider seemed to promote 
adherence (Curioso, Kepka, Cabello, Seguras & Kurth 2010:6). 
 
Although existing data is limited, some aspects of the clinical setting may be 
associated with improved adherence. A friendly, supportive and non-judgmental 
attitude of health care providers, convenient appointment scheduling and 
confidentiality contribute to better adherence 
(http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf). 
 
2.4.3.6 Other factors 
Factors such as lifestyle factors (homelessness, substance abuse) lack of 
education and mental illness affect adherence to ART (Chesney 2000:S173). 
School attendance was associated with better adherence in a study on ART 
adherence in adolescents living with HIV while unstable housing was associated 
with poor adherence (Murphy et al 2005:35; Martinez, Bell, Camacho, Henry-Reid, 
Watson & Rodriguez 2000:57).  
 
2.4.4 HIV and adolescents 
Older children and adolescents make up the largest percentage of HIV positive 
children cared for at HIV clinics globally.  In Botswana, the HIV prevalence in 




19 years. Most adolescents acquire HIV through high-risk behaviours such as 
unprotected sex or through infected injection needles. A limited but increasing 
number of HIV-infected adolescents are long-term survivors of HIV infection 
acquired through vertical transmission.  Such adolescents have been on long term 
ART experience and may have a unique clinical course that differs from that of 
adolescents infected later in life.  
 
It is important to recognize the developmental stages of adolescents when it 
comes to adherence to ART. Piaget’s cognitive theory describes the development 
of rational thought process in children. According to the Piaget’s theory, the 
concrete stage lasts between 7 and 12 years old and the formal operation stage 
after the age of 12 years of age. The phenomenon of concrete thinking may have 
implications for trying to maintain the adolescents’ adherence to ART especially if 
they are asymptomatic (Ding et al 2009:1103; MacDonell, Baar-King, Murphy, 
Parsons  & Huszti 2011:47). 
 
Certain developmental characteristics of adolescents such as their sense of 
invulnerability and difficulty in deferring gratification may present obstacles to 
acceptance of an HIV diagnosis, adherence to treatment, and use of HIV 
prevention measures (Botwinick, Bell, Johnson, Sell, Friedman, Dodds, Shaw, 
Martinez, Sicilliano, Walker & Sotheran 2003:50). Adolescent stage is 
characterized by involvement in behaviour experimentation, risk taking, 
confronting a variety of options regarding romantic relationships; sexual behaviour, 
alcohol and drug abuse (Ding et al 2009:1103). 
 
The behaviour becomes complex when the adolescent is HIV positive and has to 
manage the chronic HIV infection along with stigma that may be associated with 
the disease (Battles & Weiner 2002:161; DeLaMora, Aledort & Stavola 2006:75). 
The adolescents want to behave and act like their peers and adherence may 
become a challenge. They want to participate in all activities appropriate for their 




may also discover the realities of living with HIV and sometimes full disclosure of 
HIV status happens at this stage in their lives (Biadgilign et al 2011:e17572; 
Bikaako-Kajura et al 2006:S87). Adherence challenges may also be complicated 
by development of adverse events of ART (Ding et al 2009:1100). 
 
In a meta-analysis by Reisner et al (2009:18) it was demonstrated that concrete 
rather than abstract reasoning skills was positively associated with adherence 
measures. Williams et al (2006:e1748) found an inverse relationship between 
adherence and age. They found that adolescents aged between 15 to 18 years 
had the worst adherence (76% overall, as compared to 83-89% in the younger 
children). The relationship between adherence and age reported in that study may 




There are various ways of helping adolescents cope with issues around 
adherence to ART. A summary of strategies that can be used for enhancing 
adherence to ART include 
• Directly observed therapy (DOT) 
• Clarify instructions using a personal treatment plan 
• Tailor drug regimen to suit patients’ lifestyles 
• Show patients how to keep medication diary 
• Encourage pill sorting and convenient placement of pills 
• Encourage planning ahead for changes in daily routine (weekends and  
            holidays) 
• Make clinic appointments convenient and pleasant and provide educational  
           materials 
• Refer patients for social support, treatment of substance abuse and for 
depression and stress (Gilkman, Walsh, Valkenburg, Mangat & Marcinak 
2007:e1144; Purdy, Freeman, Martin, Ryder, Elliot-DeSorbo, Zeichner & Hazra, 




Litwin, Li, Heo & Arnsten 2011:192). 
 
Various research articles recommend directly observed therapy (DOT) to manage 
poor adherence (Gilkman et al 2007:e1144; Purdy et al 2008:159; Hart et al 2010: 
e33; Berg et al 2011:192). Gilkman et al (2007) used short duration of admission 
for specific cases of poor adherence for up to 7 days for DOT. Purdy et al (2008) 
followed up adolescents who were perinatally HIV infected and with viral load 
rebound or non-response on a stable ART regimen followed by a period of DOT in 
a clinic or hospital setting with serial viral load measurements. The research 
demonstrated that despite antiretroviral resistance, using DOT can lead to 
treatment response and therefore recommended that a period of clinic-monitored 
DOT may allow diagnosis of non-adherence.  
 
An alternative to DOT without admission to a facility is patient-nominated 
treatment supporters who provide partial DOT at home. In a randomized controlled 
trial of trained patient-nominated treatment supporters providing partial directly 
observed ART in South Africa, it was found that there was significantly better CD4 
response in the partial DOT arm compared to self-administered ART (Nachega, 
Chaisson, Goliath, Efron, Chaudhary, Ram, Morroni, Schoeman, Knowlton & 
Martens  2010:1273). Although this may be a cheaper alternative to being 
confined in a facility, further research is needed especially in the paediatric and 
adolescent population. 
 
Another promising approach to serving HIV-positive youth is family-centred care 
where members of families affected by HIV receive care at the same clinic on the 
same day as reported by Botswana-Baylor Clinic (Musa-Aisien, Anabwani & 
Kostova 2004). It would also be interesting to find out if such a model would affect 
adherence in the adolescents. 
 
In a study in the United States of America (USA), a secondary prevention 




12-sessions of behavioural intervention incorporating group and individual work 
aimed at increasing HIV knowledge, disease management and risk reduction skills 
(Chandwani, Abramowitz, Koenig, Barnes & D’Angelo 2011). Based on the high 
attendance of HIV positive youth (94%) in the intervention group, the conclusion 
was that the relatively high attendance rates suggested that youth were receptive 
to the programme and its content. 
  
The early stages of the epidemic have seen complicated drug regimens coupled 
with a high pill burden. Simplification of ART regimens may just improve 
adherence.  Maggiolo, Ripamonti, Arici, Gregis, Quinzan, Camacho, Ravasio and 
Suter (2002:375) showed that simpler regimens with a lower number of pills and 
doses may help patients’ compliance to therapy. A low pill burden, with at most 
twice daily dosing, fewer adverse events have been shown to have the greatest 
impact on patients’ ability to adhere to ART (Stone, Jordan, Miller & Pilon 
2004:808). 
 
The use of the latest technologies such as short message service (SMS) 
reminders on adherence to ART among patients have been explored in the study 
done in resource-limited setting such as a rural clinic in Kenya through a 
randomized controlled trial. The findings revealed that 53% of the participants 
receiving weekly SMS reminders achieved adherence of at least 90% during the 
48 weeks of the study compared to 40% in the control group (Pop-Eleches, 
Thirumurthy, Habyarimana, Zivin, Goldstein, de Walqe, Mackeen, Haberer, 
Kimaiyo, Sidle, Ngare & Bangsberg, 2011). This technology may eventually benefit 
adolescents struggling with adherence even in resource limited settings where 
there is access to cellular phone networks.  
 
The BBCCCOE has adopted an adherence curriculum which is meant to assist 
health care providers in tailoring the needs of adolescents with adherence 
challenges (Botswana-Baylor Clinic Website). There is need however to tailor 







HIV-infected adolescents face a challenge of adherence to ART regimens as 
illustrated in the literature search above. The various factors associated with 
adolescents’ adherence to ART in previous studies included demographics, 
psychosocial factors, HIV disease process, medication as well as provider factors. 
The literature review showed paucity of research from Botswana, specifically on 
the adherence to ART in adolescents who contracted HIV through vertical 
transmission as well as the lived experiences of adolescents regarding long-term 
ART. The significance of the study was verified by the literature review. 

























RESEARCH DESIGN AND METHOD 
 
 
3.1  INTRODUCTION 
This chapter describes the research design and methodology used to describe 
factors that influence adherence to anti-retroviral therapy in adolescents attending 
the BBCCCOE. The chapter begins with a discussion of the research paradigms 
followed by a description of the design utilised in this study. Included are details of 
the study setting, population and sampling techniques, the data collection process 
data analysis procedures as well as related ethical issues. This study was set to 
answer the following questions: 
o What are the factors influencing adherence to ART in adolescents at 
BBCCCOE? 
o What supportive interventions can be implemented to promote 
adherence to ART in adolescents at BBCCCOE? 
3.2 RESEARCH DESIGN 
A research design lays down the blueprint of how the study was conducted in 
order to maximize control over factors that could interfere with validity of the 
findings (Burns & Grove 2005:211). It guides planning and implementation in order 
to achieve the objectives of the study. The study was non-experimental and 
qualitative in nature with a descriptive phenomenology approach. The use of non-
experimental research ensured that social processes occurring in natural settings 
were observed which might not be the case with experimental research. Data was 
collected without introducing any treatment or changes to the participants.  A 
qualitative approach is used when researchers want to develop a rich 
understanding of a phenomenon as it exists in the real world and as it is 
constructed by individuals within the context of that world (Polit & Beck 2006:212). 
A qualitative design is set in the real world and natural settings (de Vos 2005:264). 
 




observation using a small number of participants because it does not presume to 
represent the wider population. Qualitative reports are presented in a descriptive 
and narrative style (Polit & Beck 2008:60). In qualitative research, people can 
describe their situations, feelings, perceptions and experiences in their own words. 
The advantage of qualitative research is the richness, individuality and the 
subjective nature of the respondents’ perspective which are not amenable to 
scientific criteria. The critiques usually levelled against it is that it is not empirical 
and that the methods used in qualitative research have not been shown to be valid 
and reliable (Polit & Beck 2006:16). 
 
In this study, a qualitative paradigm was used to allow for a deep understanding of 
adolescents living with HIV who were taking ART, to capture what they said about 
their experiences taking ART over a long period of time. The qualitative paradigm 
acknowledges the importance of the subjective experiential life-world of human 
beings, individuals’ subjectively constructed knowledge, differences in 
understanding from different individuals and multiple realities. The study is 
therefore located within the naturalistic interpretivism paradigm. A qualitative 
approach in this study allowed for a deeper understanding of factors affecting 
adherence to ART by adolescents who are experts in their own right in taking 
ART.  
 
A phenomenological approach was used to identify the phenomena of adherence 
as perceived by the adolescents in this situation. Phenomenology involves 
gathering people’s perceptions, perspectives as well as understanding a particular 
situation representing it from the perspective of the research participant (de Vos 
2005:264; Polit & Beck 2006:219; Christensen, Johnson & Turner 2011:368). A 
phenomenologist researcher examines the qualities of a participant’s experience 
through conducting interviews, getting a story or observing the participant with the 
experience of interest (Connelly 2010). Phenomenology is concerned with the 
study of experience from the perspective of the individual. Connelly further 




experience life through their physical bodies. 
 
According to Creswell (2007:58) the philosophical assumptions of a 
phenomenological study are: 
 The focus of the study is on lived experiences of the participants 
 The experiences of the participants are conscious experiences, and 
 The essence of these experiences is the focus of the research, and the 
experiences are described and interpreted rather than explained or 
analyzed. 
 
A descriptive phenomenological approach was chosen in this study. Descriptive 
phenomenology is a type of phenomenology developed by Husserl that 
emphasises the careful description of ordinary conscious experience of everyday 
life (Polit & Beck 2006:498). It was assumed in this study that the experiences of 
adolescents who were living with HIV and taking ART would give insight into what 
makes them to adhere or not to adhere to treatment. It was also assumed that 
critical truth can be found through in-depth interviews about how an adolescent 
who has been living with HIV and on ART for a long time whether with poor or 
good adherence to ART. Adolescents were expected to share their life 
experiences in this study which tell a story of why they are not adherent to ART. 
This could be through individual experience of being HIV positive and on lifelong 
therapy or in relations with the family that assist them. Adolescents with good 
adherence were also expected to share their experiences of how they are 
managing to maintain such good adherence levels. 
 
A descriptive phenomenological research approach allowed for a description of the 
experiences shared by adolescents living with HIV. The focus in this study was the 
life experiences of this special patient population in order to describe what makes 






3.3  RESEARCH METHOD 
Research methods give the logical process to be followed during the application of 
scientific methods and techniques when a particular phenomenon is investigated 
(Polit & Beck 2006:15).  
3.3.1 Sampling 
Sampling refers to the process of drawing elements from a population in order to 
obtain a sample (Christensen et al 2011:150). Sampling is also utilized in 
qualitative research even though it is less structured compared to quantitative 
research (de Vos 2005:327).The following defined the population from which the 
sample was drawn as well as the sampling process.  
 
3.3.1.1 Population  
A population encompasses the entire aggregate of cases that the researcher is 
interested in (Burns & Grove 2007:549). In this study, the population consisted of 
adolescents living with HIV and on ART being cared for at the BBCCCOE. Target 
population refers to the aggregate of cases about which the researcher would like 
to generalize (Polit & Beck 2006:511, Burns & Grove 2007:549).The target 
population for the study comprised of adolescents aged 10 to 19 years living with 
HIV and on ART attending the BBCCCOE. On the other hand, the accessible 
population is the aggregate of cases that meet the inclusion criteria and are 
available for a particular study (Polit & Beck 2006:495). The accessible population 
for the study comprised of adolescents attending the BBCCCOE clinic during the 
data collection period. The inclusion criteria for the sample of adolescents 
included: 
 Male and female adolescents aged between 10 and 19 years  
 They must have been taking ART for at least 1 year. 
 They must have contracted HIV through vertical transmission. 
 They must have signed an assent form and caregiver/parent consent form. 
The following was the exclusion criteria: 




 On ART for less than 1 year 
 HIV transmitted through other means, other than vertical transmission 
 Failure to give assent or parental/caregiver consent 
 Mentally handicapped and not capable of verbally communicating. 
3.3.1.2 Sample and sampling procedures   
A sample is a subset of the population or a set of cases selected from the 
population for a study (Christensen et al 2011:507). A sample is drawn for 
research purposes because it is not possible to study the entire population. The 
sample was selected based on the inclusion and exclusion criteria stated in the 
paragraph 3.3.3.1 above. A sample of the study participants for this study was 
drawn from is adolescents being cared for at the BBCCCOE.  
 
A non-probability sampling approach was used to select a sample of participants 
for this study. Polit and Beck (2006:505) define non-probability sampling as 
selection of sampling units from a population using non-random procedures such 
as in convenience, judgmental and quota sampling. Judgmental sampling, also 
called purposive sampling method was found suitable for the study. A judgemental 
sample comprises of participants who are likely to be able to provide information 
about the phenomenon under investigation (Burns & Grove 2005:352). 
 
In the phenomenology approach, a sample is selected on the principle that all the 
participants must have experienced the phenomenon under study and should be 
in a position to articulate what it is like to have lived the experience (Polit & Beck 
2006:274). The judgment in this study was based on the fact that HIV positive 
adolescents who contracted HIV through vertical transmission and have been on 
ART for at least a year would provide rich lived experiences regarding adherence 
to ART. 
 
Adolescents with poor/unacceptable adherence and those with good/acceptable 




electronic medical record system which documents adherence at every visit. The 
list of adolescents who contracted HIV through vertical transmission and were on 
ART for more than a year attending clinic was used to select the adolescents. 
Adolescents were sampled at a ratio of 1:1 for good/acceptable and 
poor/unacceptable adherence. Participation was only upon signing of an informed 
consent and assent. 
 
3.3.1.3 Sample size estimation  
The sample size could not be determined in advance, however, the minimum 
requirements for qualitative research were adhered to namely, data saturation  
Data saturation is reached when no new data is generated during the data 
collection phase (Polit and Beck 2008:759). In qualitative research, sample size is 
usually determined based on informational needs (Polit & Beck 2006:273).  
 
3.3.1.4 Research setting   
A study setting is the physical location and conditions in which data collection 
takes place (Polit & Beck 2006:510). The study was conducted at the BBCCCOE, 
a public-private partnership clinic situated at the largest referral hospital in 
Botswana which takes care of HIV positive children from birth up to 21 years. The 
BBCCCOE is a referral centre for all complicated paediatric HIV cases including 
psychosocial complexities. The centre accepts referrals from all over peripheral 
facilities in Botswana. The centre has been operational since 2001 and it has 
many patients in their 9th year of ART and beyond, many of whom are now in their 
adolescent ages.  
 
Services offered at the clinic include paediatric patient consultations for the HIV 
positive (including the caregivers and parents), counselling, initiation of ART and 
follow up care. Beyond the clinic, the staff also does home visits to patients with 
complex family situations especially when related to adherence issues. There are 
currently more than 2 000 patients on ART (Inclusive of the 618 adolescents) 




physicians as well as infectious diseases specialists. The nursing staff, social 
workers and psychologists form part of the health care team at this clinic.   
 
3.3.1.5 Ethical Issues related to sampling  
Justice  
Justice refers to fair and equal treatment accorded to all participants. In this study 
inclusion and exclusion criteria were used to select study participants irrespective 
of gender or social status of the adolescent.  
 
3.3.2 Data collection  
Burns and Grove (2007:536) define data collection as precise and systematic 
gathering of information relevant to specific research objectives or questions. 
Christensen et al (2011:274) stipulates that a researcher should adhere as closely 
as possible the data collection procedure as planned. 
 
3.3.2.1 Data collection approach and methods 
Interviews were used as the main data collection method. An interview is a 
scenario where an interviewer asks the interviewee a series of questions and can 
be conducted face-to-face or over the telephone (Christensen et al 2011:56). In-
depth interviews, defined by Boyce and Neale (2006:3) as a technique that 
involves conducting intensive individual interviews with a small number of 
respondents to explore their perspectives on a particular situation were used. In-
depth interviews provide for detailed information about a person’s thoughts and 
behaviours. The interviews were semi-structured. A semi-structured interview 
involves a list of topics or broad questions that must be addressed in an interview 
called the interview guide to ensure that all questions are covered during the 
interview (Polit & Beck 2006:291). 
 
In-depth individual semi-structured interviews were chosen for this study in order 
to gain a deep understanding of how adolescents living with HIV managed their 




poor/unacceptable adherence but also those doing well with adherence (with good 
adherence). Information was collected from both sides allowed for a comparison 
and to build an intervention approaches. The disadvantages of in-depth interviews 
are that they are prone to bias, can be time intensive, results not generalizable 
and require a certain level of expertise of the interviewer (Boyce & Neale 2006:3).  
 
3.3.2.2 Data collection instruments 
The interview guide was used as data collection instrument. It consisted of 
questions written to guide the interviewer in order to cover all areas required (Polit 
& Beck 2006:291). Open ended questions were used to enable the participants to 
talk freely about all topics on the guide and the probing questions were used as 
needed for additional information or clarification. The interview guide consisted of 
an introduction (including informed consent), a set of questions and closing 
comments (See annexure 9). 
 
3.3.2.3 Data collection process 
The interviews were conducted in a private consultation room which was not in 
use for general consultations giving study participants privacy to share their 
experiences. They were conducted in English by the researcher. However, a study 
nurse was available to translate if there was a need to do so. The researcher 
created a favourable, non-threatening environment by introducing himself to the 
participants, explaining the purpose of the interview and thanking them for their 
willingness to take part in the interviews. The participants were assured that the 
data gathered during the interview would be treated as highly confidential and it 
would not be reported in a manner that identifies or links them with the information. 
The consent to participate in the study was confirmed before the commencement 
of the interviews. 
 
With the permission of the participants, all the interviews were audio-recorded and 
notes were taken during the interview in order to capture all the information and/or 





One of the advantages of data collection through the use of interviews is that the 
interview focuses directly on the study topic and it is insightful. However if the 
questions are not well constructed, there could be bias, inaccuracies due to poor 
recall or the participants may give what they think the researcher wants to hear 
(Polit & Beck 2008:424).  
 
One specific issue in this study was the researcher’s dual role. The researcher 
was a regular consulting doctor for most of the adolescents who participated in the 
study. This may also have introduced bias as the adolescents try to please the 
interviewer who is the regular consulting doctor. This is called a reactive effect as 
interviewees might try to show only what is socially desirable (Christensen et al 
2011:58). The researcher developed an interview guide which comprised of open-
ended questions.  
 
Interviews require a certain level of expertise of the interviewer (Boyce and Neale 
2006:3). The researcher used various communication skills such as paraphrasing, 
reflection, listening and probing to enhance understanding, to guide the 
participants to elaborate on their responses and to give additional information 
where it was required (de Villiers & van der Wal 2004: 243). These skills enabled 
the participants to respond freely to open-ended questions using their own words, 
sharing their own stories with the researcher and to give in-depth information 
regarding their experience pertaining to long-term ARV.  
 
Data collection was continued until data saturation was reached. If the 
respondents are good informants and are able to reflect on their experiences and 
communicate effectively, data saturation may be obtained with relatively few 
respondents. This was done as suggested by Tuckett (2004:53) through: 
 Constant comparison of data 
 Redundancy of themes.  




Data saturation was reached after 8 interviews were conducted. 
 
3.3.2.4 Ethical issues related to data collection  
Ethical issues to pay attention to consider regarding data collection include 
consent, protection of the rights of institutions, privacy, confidentiality and potential 
to harm (Allmark, Boote, Chambers, Clarke, McDonnel, Thompson and Todd 
2009:48). 
 
Protecting the rights of the institution 
The research was approved by the department of Health Studies, University of 
South Africa (UNISA), the Health Research Development Committee (HRDC) with 
the Ministry of Health, Botswana and the Baylor College of Medicine (BCM) ethics 
committee. Permission to conduct the study was given by Botswana-Baylor 
Children’s Clinical Centre of Excellence. 
 
Informed consent 
The researcher provided detailed information regarding the purpose and nature of 
the research to the participants and those who agreed to take part in the study 
signed a consent form. The informed consent covered four essential elements 
namely disclosure of essential information, comprehension, competency and 
voluntarism (Burns & Grove 2005:193).  The participants were also informed of 
their right to decline to participate in the study or withdraw from the study at any 
point without explanation or consequences even though they had already signed a 
consent form. Letters of permission appear as Annexure 1, 3 and 4.  
 
The researcher also explained the benefits from the study that once factors 
influencing adherence have been identified, the health care providers will be able 
to better manage adolescents’ ART adherence issues and participants could 
benefit from interventions proposed to address adherence issues in the 
adolescents on ART (See Annexure 2, MOH Botswana Ethics application form). 




in the study (see annexure 5, 6, 7 and 8). The child also signed an assent. The 
informed consent and assent were obtained by the researcher in the presence of a 
study nurse.  
 
Confidentiality, Anonymity and Privacy 
Confidentiality refers to researcher’s responsibility to prevent the data gathered 
during the study from being divulged or made available to any other person 
Confidentiality was upheld at all times and information shared with participants 
shall not be shared without permission. The participants were assured that the 
information would be used for the purpose of the research only and the results of 
the research would be made available to them on request. Interviews were 
conducted in a separate consultation room. No identifiers were included in the field 
notes or the voice recorder and data was treated anonymously.  
 
Non-maleficence 
This principle of non-maleficence refers to the researcher’s duty to avoid, prevent 
or minimize harm to study participants (Polit & Beck 2006:87). This study involved 
minimal risk and potential emotional discomfort. A clinical psychologist was 
available at the centre for counselling if the need arose (see annexure 11 and 12). 
There were no incidences of emotional upsets during the study. 
 
Beneficence 
Beneficence is a fundamental ethical principle that seeks to prevent harm and 
exploitation and at the same time maximizing benefits for study participants (Polit 
and Beck 2006:496). There were no direct benefits to study participants. Potential 
benefits were for adolescents living with HIV if interventions suggested were 
implemented to help with adherence to ART. 
 
Reflexivity activity  
It is important to address the issue of power relations during interviews. Reflexivity 




especially in understanding one’s influence or role in a set of human relations (de 
Vos 2005:363). Alex and Hammarstrom (2008) warn that power relations can be 
created within an interview situation hence it is important to be aware of dominant 
perspectives. Reflexivity was employed by the researcher (being aware of his 
position as a consulting doctor) to assure the study participants and encouraging 
them to share their experiences. However the researcher did not document his 
own cognitive world going into these interviews. 
 
Bracketing 
This refers a cognitive process of putting aside one’s own beliefs. Being non-
judgemental and remaining open to data as they are revealed and is carried out 
before and during data collection and analysis (Streubert & Carpenter 2003:25). 
The researcher, being a consulting doctor for some of the study participants 
ensured that there were no preconceived notions especially based on adherence 
status and remained neutral during data collection and analysis. By bracketing 
own experiences, the researcher was able to leave the position of a consulting 
doctor and get down to the study participants to understand their experiences as 
they take ART over a long period of time. However the researcher did not 
document his thought process of preconceived notions or ideas going into the 
interviews. 
 
3.4  DATA ANALYSIS 
The data analysis for qualitative research is an active and interactive process 
(Polit and Beck, 2006:398). Morse and Field (1995) cited in Polit and Beck 
(2006:398) note that qualitative data analysis is a process of fitting data together, 
making the invisible obvious and linking and attributing consequences to 
antecedents. The purpose of data analysis is to organize, provide structure to, and 
elicit meaning from the data (Polit and Beck 2006:397). Data collection was done 
in English by the researcher and the collected data was preserved electronically. 
Thematic analysis according to Van Manen (1990) cited in Polit & Beck (2008: 




Manen, thematic aspects of experience can be uncovered or isolated from the 
participant’s description of the experience.  
 
Holistic approach 
In holistic approach, the researcher reviews the text as a whole and tries to 
capture the meaning (Polit & Beck (2008: 519). The tape recorded interviews were 
first transcribed verbatim into text as Microsoft word document. The researcher 
read through each transcript to familiarise self with the data, get a sense of the 
whole and to search for meaningful segments or units. The researcher also 
listened to audio recordings of each transcript in order to verify the transcriptions. 
 
Selective approach 
In this approach, the researcher highlights or pulls out statements or phrases that 
seem essential to the experience under study (Polit & Beck (2008: 519). While 
reading the transcripts, the researcher made notes of any thoughts, observations 
and reflections that occurred. The notes comprised of recurring phrases, words or 
group of words with similar meaning or connotations. 
 
The researcher then identified themes from within each section of the transcript. A 
theme is an abstract entity that brings meaning and identity to a current 
experience and its variant manifestations (Polit & Beck 2006:404). Once the 
themes have been identified they become the object of reflection and 
interpretation through follow-up interviews with participants (Polit & Beck 
2006:521). The final step involved weaving the thematic pieces together into an 
integrated whole to provide an overall structure to the data. The themes were 
clustered into identifying factors associated with adherence to ART.   
 
The researcher suspended his presuppositions and judgments in order to focus on 
what was actually presented in the transcript data by means of bracketing.  The 
main features and concerns regarding adherence to ART uncovered from the 




with evidence from the interview, using a quotation which the researcher felt best 
captured the essence of the person's thoughts, and their emotions about the 
experience of the phenomenon being explored.  
 
3.5 MEASURES TO ENHANCE TRUSTWORTHINESS 
The primary concern in qualitative research is not validity/reliability but 
trustworthiness. The criteria used for establishing trustworthiness include 
credibility, transferability, dependability and confirmability. 
 
Credibility is the confidence in the truth of data and interpretations of them (Polit 
&Beck 2006:332). Prolonged engagement with the study participants was done in 
order to understand in-depth factors associated with adherence. Prolonged 
engagement is also important in order to build trust and rapport with participants. 
First contact was made to obtain assent and then to request consent from 
caregiver/parent and this was followed by the in-depth individual semi-structured 
interviews. This repeated contact enhanced credibility as the adolescent built trust 
in the process.   
 
Dependability refers to data stability over time and over conditions and there can 
be no credibility in the absence of dependability. Dependability is similar to 
reliability in quantitative studies (Polit & Beck 2006:335). Audio tape was 
transcribed by the researcher and this was cross-checked with the field notes 
taken by the researcher. 
 
Confirmability refers to the neutrality of the data, that is, the potential for 
congruence between two or more independent people about data’s accuracy, 
relevance or meaning (Polit & Beck 2006:336). Confirmability in this study was 
enhanced by the availability of raw data on tape and transcriptions to verify the 
themes. The use of bracketing prior to data collection ensured the pure description 
of data. All pre-conceived ideas regarding the adolescents' adherence to ART 




part of the audit trail that was kept by the researcher. 
 
Transferability refers to the extent to which findings from the data can be applied 
to other settings or groups and is thus similar to the concept of generalizability 
(Polit & Beck 2006:336). A detailed report (thick description) of the findings of this 
study provided sufficient information to permit judgements about contextual 
similarity. Based on the integrity of this study, other settings may decide on the 
applicability of the findings to their settings. The use of purposive sample of 
adolescents increased transferability.  
 
3.6 CONCLUSION 
The research paradigms, the design and the research method utilised in this study 
were described as well as related ethical issues. The next chapter focuses on 






















 CHAPTER 4 
ANALYSIS, PRESENTATION AND DESCRIPTION OF RESEARCH FINDINGS  
 
4.1 INTRODUCTION 
In this chapter, the research findings (including the literature control) of the study 
are presented. The findings were deduced from the analysis of the participants’ 
interview transcripts as well as the researcher’s observational and personal notes 
regarding the factors that influence adherence to antiretroviral therapy among 
adolescents attending the Botswana-Baylor Children’s Clinical Centre of 
Excellence.  
 
4.2 DATA MANAGEMENT AND ANALYSIS 
The method of data collection used was in-depth individual semi-unstructured 
interviews. The researcher used an interview guide to collect data from the 
adolescents who contracted HIV through vertical transmission and had been 
taking ART for at least one year.  The aim was to explore and describe the factors 
that influence their adherence to ART. Observational notes describe the events 
experienced through watching and listening whereas the personal notes are 
reflections of the reactions and experiences of the researcher (de Vos 2002:33). 
The participants consented to the use of an audio recorder during the interview. 
The collected data was preserved electronically.  
 
Thematic analysis of data was done according to Van Manen (1990) cited in Polit 
and Beck (2008: 519) using the holistic and the selective approaches. According 
to Van Manen, thematic aspects of experience can be uncovered or isolated from 
the participant’s description of the experience. Themes and categories were 
identified from the data. The themes that emerged provided in-depth 
understanding of the factors that influence adherence to antiretroviral therapy 





4.3 RESEARCH RESULTS 
 
4.3.1 Sample description 
The adolescents who participated in this study contracted HIV through vertical 
transmission and had been taking ART for at least one year. The minimum 
number of years that the study participants had been on ART was 4 years and the 
maximum was 9 years. These study participants therefore had a rich experience of 
long-term ART use from which factors that influence adherence to ART could be 
identified. 
 
There were 5 female participants and 3 male participants aged between 14 and 19 
years. There were equal numbers of adolescents with poor/unacceptable and 
good/acceptable adherence. The first interview was conducted on the 9th of 
August 2011 and data collection continued until saturation was reached with 8 
participants. 
 
4.3.2 Themes  
Five (5) themes emerged from the data analysis. The themes were identified as 
reflecting the factors influencing adherence to antiretroviral therapy among 
adolescents.  
 
4.3.2.1 Theme 1: Knowledge and positive beliefs about ART  
The first theme that emerged related to knowledge and positive beliefs about the 
effectiveness of ART. Within the theme, two categories 'belief in the benefits of 
ART' and 'adherence to ART ' emerged and the subcategories are as shown in the 









TABLE 4.1. THEME 1: Knowledge and positive beliefs about ART 
NO THEME CATEGORIES SUBCATEGORIES 
1 Knowledge and positive 
beliefs about  ART  
Belief in the benefits 
of ART 
 
Adherence to ART. 
 
Effect of ART on the HIV and HIV 
related diseases (4.3.2.1a) 
Effect of adherence to ART on 
the levels of the HIV in the blood 
(4.3.2.1b).  
Personal experience and attitude 
towards  ART (4.3.2.1c). 
 
 
4.3.2.1a. Effect of ART on the HIV and HIV related diseases  
The participants expressed their belief in the benefits of ART and demonstrated 
substantial knowledge that ART suppresses the HIV virus and stops the 
progression of HIV disease as follows:  
“Well, I told myself that if i don’t take my tablets i will be sick” (18 year old 
female) 
 
“I think there is no cure for HIV and this is all there is.....Unless if there is 
something now (smiling)” (18 year old female) 
“Aah, I mean it’s ok that there are ARVs to help when I am sick but then it 
also means (16 year old male) 
“That I have to continue with them for the eh….the rest of my life (16 year 
old male) 
4.3.2.1b. Effect of adherence to ART on the levels of the HIV in the blood  
The participants demonstrated correct knowledge that if ART is taken reliably and 
correctly, the drugs can reduce the virus level in the blood, restore the immune 




improve the quality of life.  This correct knowledge was apparent in the comment 
of one participant who stressed: 
 
“I know if i don’t take them properly my soldiers (referring to CD4) will go 
down and the bad guy (referring to HIV) will wake up and i will be sick (15 
years male). 
 
4.3.2.1c. Adherence to ART  
There were self-reports of adherence and non -adherence to ART from the 
participants, the ratio of which was 50:50. 
 
“...(pause)..I take my meds every morning and evening (14 year old male) 
 
“...I just take them....every day...” (15 year old male) 
 
“I take 6....That’s a lot but what can i do” (18 year old female) 
 
“I know why i take them!” (18 year old female) 
 
4.3.2.1d. Personal experience and attitude towards ART  
The following were some of the experiences shared by participants on their 
personal experience and attitude towards ART: 
 
“For me I remember I was sick when I started the meds and I became well after 
starting the tablets. So they are helping me” (17 year old male) 
“Why do i have to take them anyway...” (14 year old female 






Belief in the benefits of ART: Literature control  
The participants demonstrated substantial knowledge about the benefits of ART 
but the knowledge was not consistent with adherence levels. This finding is 
supported by a quantitative study on factors influencing non-adherence to ART by 
Nyambura (2009:52). The majority of participants in that study knew that ART 
reduces the viral load and therefore prevent progression to AIDS. However, the 
findings of that study revealed no association between knowledge and adherence 
to ART. Nyambura (2009:53) points out that despite patients knowing the benefits 
of ART and the importance of adherence, there were other factors like stigma, 
missed clinic appointments that made them to default.  
 
Knowledge about ART, belief in ART and personal experience on ART were 
identified as factors affecting adherence (Chirag 2007:56).  Curioso et al (2010) 
conducted a qualitative study on the facilitators and barriers to antiretroviral 
adherence and the findings showed that positive beliefs about medication promote 
adherence.  Factors such as doubting the efficacy of HAART, uncertainty of long-
term effects and unwanted changes in body image were barriers to adherence to 
treatment (Mills et al 2006). 
 
Adherence to ART 
Adherence to ART can be measured in a variety of ways. Miler and Hays (2000) 
identified patient self-reported adherence as one of the approaches to measure 
adherence in patients on ART. There were self-reports of adherence and non-
adherence to ART from the participants at the ratio of 50:50. 
 
The participants who maintained good adherence acknowledged that it had been 
very difficult for them to be on ART for such a long time, but they persevered. 
These expressions did not however show loss of hope in these participants but it 
was just an expression of how difficult it had been for them all the years that they 






“Aah, it’s not easy.....ah” (18 year old female) 
 
“Ah, I think for me it’s been difficult even though somehow I managed.....” (18 
year old female) 
 
“Ummm, I don’t know how I have managed, but I have…..God has been 
helping me (pause)…you know (14 year old female) 
The researcher asked the participants who maintained good adherence a question 
in the interview guide: What advice would you give to a friend who is 
struggling with adherence to ART? The following are some of the responses: 
“..If they don’t take their ART they will be sick. Don’t wait until you are sick. 
Like what happened to me” (18 year old female) 
 
“I think it’s up to them really. If the tablets are working for you keep taking, 
but I think they always work” (17 year old male) 
 
The participants who do not adhere to ART expressed various reasons for non-
adherence which included lack of motivation and pill fatigue. Pill fatigue was 
apparent in the following expressions of the participants: 
 
“I am tired….. I mean, how long will I take them?” (19 years old female) 
 
“…ah, I just stopped, nothing had happened, I was tired and I just woke up 
and decided….better stop them” (19 year old female) 
 
“It’s not an easy thing to do. It means every day you take your tablets, 
many of them” (18 year old female) 





Adherence to ART: Literature control 
In a qualitative study on adherence to ART among HIV positive American 
adolescents, the results showed that only 41% reported taking all the prescribed 
treatment (Murphy et al 2001:27).  Such low levels of adherence can easily lead to 
the development of viral resistance. Other studies done on adherence and 
intervention among HIV-infected in the United States on HIV and AIDS, found that 
youth overall rates of adherence in the 30 days prior to study enrolment ranged 
between 28.3% to 69.8% (Reisner et al 2009:15).  
The findings of this study are consistent with those of a study on  medication -
related factors affecting adherence by Chesney (2000:S171) which revealed that 
pill burden and lack of belief in the effectiveness of medication affected adherence 
to ART and that a low pill burden was associated with improved adherence. 
4.3.2.2 Theme 2: Need for support 
The second theme that emerged related to the need for support, three categories 
'family support', ‘friends'  and 'society' emerged and the subcategories as shown in 
the table 4.2 below. Each subcategory will be discussed below. 
 
TABLE 4.2. THEME 2: Need for support 
NO THEMES CATEGORIES SUBCATEGORIES 
2 Need for support Family support 
Friends  
Community   
Assistance with taking 
medication (4.3.2.2a) 
Disclosure of HIV 
status(4.3.2.2b) 








While sharing their experiences on ART, the adolescents in this study with good 
adherence acknowledged the importance of support from family, friends and the 
society. The family comprised of parents, siblings, grandmothers, aunties and 
caregivers. 
 
4.3.2.2a. Assistance with taking medication 
The adolescents expressed appreciation of the assistance regarding medication 
that they receive from family while others had no support of family. 
  
“Ever since my parents died, my grandmother has had to take care of me. I 
have a sister who also helps, but my grandmother really helped” (18 year old 
female) 
 
“Yes she does help me, she reminds me” (18 year old female referring to 
sister) 
 
“My mum helps me and....” (17 year old male) 
 
“My mother keeps them and she tells me when it is time and I take them” (15 
year old male) 
 
“My parents remind me sometimes” (14 year old female) 
 
“My mum doesn’t have to take them; no one has to take them” (18 year old 
female) 
 
“....sometimes I forget. You know i am always home by myself most of the 
times. My mother works at night sometimes...ah..(looking down)” (18 year old 
female) 
 





“She is at work most of the times; she leaves in the morning so sometimes I 
have to remember my meds without her” (16 year old male referring to an aunt) 
 
“They died… (No eye contact)….(pause). I stay with my grandmother and 
grandfather and my sister. My auntie is at the cattle post” (19 year old female) 
 
Family support: literature control  
Family plays an important part in any kind of treatment. Family support may 
improve adherence or assist people living with HIV to maintain high levels of 
adherence. This finding agrees with studies in USA and Belgium that positive 
interpersonal relationship made adherence to ARV treatment successful (Mills et 
al 2006). The use of family members and peers to enhance ART adherence has 
emphasized the importance of social support in the treatment of HIV patients.  
 
Bikaako-Kajura et al (2006:S88) reported in their study that older adolescents who 
had strong and supportive child-caregiver relationships were able to achieve good 
adherence even where disclosure of HIV status had not taken place. According to 
Castro (2005) and Mills et al (2006), not living alone, having a partner, social or 
family support, peer interaction and better physical interactions and relationships 
are characteristics of patients who achieve optimal adherence.  
In Uganda, children enjoyed a supporting and trusting relationship with their 
primary caregivers and this promoted disclosure as well as adherence (Bikaako-
Kajura et al 2006) In this study the researcher found that adolescents who 
expressed support from family and caregivers adhered to ART.  
Curioso et al (2010:4) reported that interpersonal relationships were very important 
to be considered when looking for facilitators of adherence. In their study, Curioso 
et al found that family and friends reminded the participants to take their ART while 




the adolescents reported that family members reminded them to take ART. 
 
4.3.2.2b. Disclosure of HIV status 
The adolescents who were interviewed had disclosed their HIV status to family, a 
few to friends and one to the teacher. Disclosure was mentioned by the 
adolescents with good adherence to ART (taking her ART at school) while those 
with poor adherence were secretive about their HIV status: 
 
“I just take them....ah! No one cares” (18 year old female) 
 
“My friend and my guidance teacher know” (18 year old female) 
 
“Ah, of course no…… Eish, that’s my secret akere…… Ah ah, what if he tell 





Disclosure of HIV status: Literature control 
The finding is supported by Biakaako-Kajura et al (2006:S89) who reported that 
children were self-motivated to adhere to their ART following full disclosure of HIV 
status. The adherence motivation reported by Biakaako-Kajura (et al 2006) and 
other researchers came from the child knowing his/her HIV serostatus and 
understanding why ART was needed. Again stigma and discrimination by friends 
and family members were strongly associated with non-adherence to ART 
(Phalade et al, 2009; Miles et al 2006). 
 
Biadgilign et al (2011:e17572) in their study were dealing with only 17.4% 
disclosure level and they found that non-disclosure was associated with poor 
adherence. In their study, Biadgilign and others showed that only 46.2% of the 




demonstrates the variation which exists on disclosure yet there are clear benefits 
to disclosure of HIV status. It is through disclosure that a child or adolescent can 
understand what it means to be HIV positive and disclosure and the knowledge of 
HIV would be facilitators of adherence. 
  
There are pros and cons of HIV disclosure and in a study by Ayres et al 
(2006:1002), caregivers’ narratives indicated that delaying disclosure of HIV 
infection was a common measure taken to protect adolescents. The caregivers in 
this study believed that mischaracterisation of the “abnormality” represented by 
HIV infection might result in disclosure bringing more benefits than harm. However 
in this study early disclosure and acceptance of HIV status was more common in 
those adolescents with acceptable adherence. 
 
Sometimes these adolescents may not disclose for fear of stigma and 
discrimination. Stigma and discrimination is clearly associated with poor 
adherence as demonstrated in a systematic review by Reisner et al (2009:15). 
Adolescents may also discover the realities of living with HIV and sometimes full 
disclosure of HIV status happens at this stage in their lives (Biadgilign et al 
2011:e17572; Bikaako-Kajura et al 2006:S87). In-depth interviews with 
adolescents living with HIV aged between 10 and 20 and their caregivers at six 
different AIDS treatment centres in Sao Paulo, Brazil also identified stigma and 
discrimination as the most important challenges in living with HIV (Ayres et al 
2006:1004). 
 
In this study being secretive about HIV status (meaning no disclosure) was found 
in those adolescents with poor adherence to ART which may imply that being 








4.3.2.2 c. Stigma and social discrimination  
Stigma and discrimination was mentioned only as one of the reasons one 
participant (in the group that did not adhere to treatment) did not disclose their HIV 
status. 
 
“Ah, of course no…… Eish, that’s my secret akere…… Ah ah, what if he tell 
others….(laughing).” (16 year old male referring to why they did not 
disclose) 
 
Stigma and social discrimination: Literature control 
The finding is consistent with a study by Phalade et al (2009) who investigated 
challenges faced Botswana adolescents living with HIV in and found that stigma, 
discrimination, HIV disclosure were strongly  associated with   non- adherence. 
Miles et al (2006) found that people who are open and had told their friend and 
family members about their HIV status were supported during ART treatment. 
Another finding of the same study by Miles et al (2006) was a significant 
relationship that exists between stigma and adherence to ART.  
 
In a review by Reisner et al (2009:15), HIV stigma and discrimination by friends 
and family members were strongly associated with non-adherence to ART 
showing the importance of a stable home environment and at least support from 
the family. This showed that family support or a stable home environment with no 
stigmatization as at least supportive for an adolescent child on ART.  According to 
Nyambura (2009:70) stigma, discrimination, lack of family and community support 
is huge obstacles to ART adherence. 
 
4.3.2.3 Theme 3: Difficult and complicated treatment  
The third theme that emerged related to difficult and complicated treatment and 
the categories that emerged include life-long treatment and type of medication. 






TABLE 4.3.  THEME 3: DIFFICULT AND COMPLICATED TREATMENT 
NO THEMES CATEGORIES SUBCATEGORIES 
3  ART difficult and 
complicated treatment 





Type of medication 
Side -effects  (4.3.2.3a) 
 





Size of pills (4.3.2.3d) 
 




Missing doses (4.3.2.3f) 
 
failure to commit to lifelong 
Treatment (4.3.2.3g) 
regular doctor (4.3.2.3h) 
 
 
The participants who did not adhere to treatment said that they forgot to take ARV 
drugs; they missed their treatment doses due to fear of stigma or disclosure.  They 
mentioned pill burden as the cause of them to miss their treatment doses. 
 
4.3.2.3a. Side -effects  
Reports of patients vomiting or having stomach cramps were reported as what 
makes it difficult to maintain a good adherence to ART in adolescents interviewed 
in this study. These are the sample responses:  
 




the time” (19 year old female) 
 
“Sometimes I vomit and waking up in the morning to take them before 
going to school is difficult” (14 year old female) 
 
“And then sometimes I vomit eish….. (pause). It’s difficult” (16 year old 
male) 
 
“Aah…sometimes I vomit in the morning….so maybe better tablets. Gape, 
eish….if also get that tablet for taking at night only, maybe it will help” (14 
year old male) 
 
Side-effects: Literature control 
Side effects to ART have been implicated in some studies as negatively affecting 
adherence (Maggiolo et al 2002:371; MacDonnel et al 2011:50). MacDonnell et al 
reported in their study exploring situational temptation that the three most tempting 
situations to miss medications as: 
 If medicine caused physical symptoms 
 If the medicine caused stomach upset or nausea or had an unpleasant 
taste and 
 If the youth simply forgot to take the medication. 
All these three situations are described in this study and some of the side effects 
may be long term. MacDonnell et al recommended that youths’ expectations of 
negative physical symptoms should be addressed in the first instance when 
considering beginning an HIV treatment regimen. 
 
4.3.2.3b. Interference with daily activities/routine  
Taking ART was a challenge for the participants especially as it is related to 
morning school start times or disturbed when they travelled. The following were 





“Ah… (smiling), akere it means we can’t play together all the time, I have to 
run home to take my meds all the time” (16 years old male) 
 
“...it’s not easy...I wake up early in the morning, and if it is during school 
terms I have to quickly prepare for school, eat and then take my medicines 
at 7” (18 year old female) 
 
“The last time I forgot them when I went to masimo (lands)….eish…” (16 
year old male) 
 
“… (pause).. and I have to take them same time every day, that’s hard” (19 
year old female) 
 
“Gape, eish….if also get that tablet for taking at night only, maybe it will 
help” (14 year old male) 
 
 
Interference with daily activities/routine: Literature control 
Curioso et al (2010:4) reported that they identified many factors related to daily 
schedules which could improve levels of adherence and this included having a 
fixed routine and the use of adherence tools. Curioso et al found that having a 
fixed routine was the top adherence facilitator in their study. Similarly MacDonnell 
et al (2011:50) reported that if the ART regimen got in the way of a participant’s 
daily schedule or if family and/or friends did not help support and remind 
participants to take their medications adherence would be affected. 
 
Murphy et al (2003:254) also demonstrated that adherence was tied closely with 
daily routine which supports the assumption that working closely with adolescents 
to improve their organisational skills may be necessary to improve adherence. 
Fitting the ART doses into the daily routine was the challenge expressed by the 





A change in daily routine was reported in 40% of patients as a reason for 
nonadherence in many studies (Chesney 2000:S173). A change in daily routine 
was also cited by Murphy et al (2003:252) in their study in adolescents on ART. 
This means that if anything changes during the morning or evening, the ART 
doses may easily be forgotten. 
 
4.3.2.3c. Forgetfulness  
Forgetting to take ART was a common experience expressed by adolescents who 
had poor adherence. Adolescents with good adherence who admit to forgetting to 
take their ART usually have corrective measures such as taking immediately one 
remembers. The following statements were expressed:  
 
“Sometimes I forget I have to take every day” (14 year old female) 
 
“Eish…. (pause, looking down)…I told you it’s difficult. I try to take them but 
then….eish, sometimes I forget” (18 year old female) 
 
“I don’t like the tablets. You are not supposed to forget them, you are 
supposed to eat before taking them, eih. Mathatha” (19 year old female) 
 
“Yes….That means that before I go to school I take, that is when I wake up. 
And then in the evening after school I take. So if I forget in the morning and 
remember when at school…. I forget. Then in the evening I come home, but 
if there is sports and I come late, I take them late…eish. Then sometimes I 
forget” (16 year old male) 
 
 
Forgetfulness: Literature control 




Brazil and Botswana that showed forgetfulness, fear of side effects and pill burden 
as reasons for ART non-adherence (William and Fourney 2000; Mills et al 2006). 
 
In a review, Chesney (2000:S173) demonstrated that just forgetting or being busy 
was the commonest reason for non adherence with a prevalence of between 34% 
and 52%, this was followed by being away from home with 27-42%. Some of the 
reasons for forgetting in this study included travelling as well as the fact that it is 
supposed to be a daily habit and some end up forgetting. 
 
Murphy et al (2003:252) found three most commonly endorsed reasons for non-
adherence to ART in adolescents to be simply forgot (45.6%), did not have 
medication with them (42.1%) and change in daily routine (33.3%). In another 
study, Maggiolo et al (2002:374) found, forgetfulness was reported in 59.3% of the 
participants while being away from home was reported in 50.2%. Being away from 
home was similar to what was reported in this study. 
 
 Use of electronic devices 
The adolescents who adhered to ART mentioned the family members remind them 
to take medication, but they also use electronic reminders. The use of reminders 
ranged from alarm clocks, cell phones. There were some adolescents in this study 
who acknowledged the use of reminders such as alarms as what has been helping 
them over the years to maintain a good adherence to their ART. Their experiences 
showed these reminders as facilitators of adherence as shown by the following 
statements: 
 
“I always use my alarm to remind me as well” (17 year old male) 
 
“...my grandmother helps and i also have an alarm clock (18 year old 
female) 
 





“I set a reminder on my cell phone and it reminds me” (14 year old female) 
 
“My auntie reminds me and I also check the time on the radio or 
TV….(pause). But if I had an alarm then it can remind me like when I am at 
school (16 year old male) 
There were adolescents mentioning the use of reminders as what motivates them 
to maintain good adherence as shown by the following statements: 
“Sometimes my mother sets an alarm for me. But she won’t buy me a cell 
phone” (15 year old male) 
“My friend uses a cell phone” (15 year old male) 
 
The use of electronic devices such as alarm clocks, alarm watches as well as cell 
phones has long been recognized as a facilitator of adherence in all age groups. 
According to Mannheimer, Hirsh and El-Sadr (1998) adherence improved to 100% 
in 98% of patients using a specific alarm device indicating the importance of 
adherence supporting tools such as alarms even during the early stages of the 
HIV epidemic. The use of adherence supporting tools was also confirmed in a 
review paper by Chesney et al (2000:S174). In a study in Ethiopia on adherence in 
the paediatric population, researchers found that caregivers used reminders from 
cellular phone alarm systems (25.4%) followed by watches/clocks (46.4 %.) 
(Biadgilign et al 2008:58). The tools mentioned in Ethiopia by Biadgilign et al were 
similar to the findings in this study. The use of reminders through alarm clocks and 
cell phone was found to be a facilitator of adherence in this study. 
Another question that was asked to study participants whether with poor or good 
adherence was the kind of help that they would ask for from the clinic or the 
government. Another adherence tool which helps to manage and remind to take 




“A pill box…..It organizes your tablets and you can always see when you 
have not taken them”. (18 year old female) 
“It organizes your tablets and you can always see when you have not taken 
them” (18 year old female) 
In a marginal structural model analysis study on pillboxes as adherence tools, 
Peterson, Wang, van der Laan, Guzman, Riley and Bangsberg (2007) estimated 
that pill boxes improved adherence by 4.1% to 4.5% and was associated with a 
decrease of viral load of 0.34-0.37 log10 copies/ml and a probability of viral 
suppression. The use of pill boxes is fairly inexpensive and Peterson et al were 
recommending the pill boxes to be a standard intervention to improving adherence 
to antiretroviral therapy. 
Cell phones can be used as alarm clocks to set reminders but also the short 
messaging system (sms) can be used to send reminders. The use of mobile 
technology to improve adherence to ART has been documented and this followed 
the study on sms reminders in Kenya (Pop-Eleches et al 2011). There are other 
studies which have demonstrated benefit from the use of electronic reminder 
devices (Wise and Operario 2008). 
At the time of this study at BBCCCOE there was a pilot project on the use of sms 
reminders and some of the clinic patients were participating on the project. The 
following were some of the statements mentioned by the adolescents regarding 
the use of this new technology: 
“...I also want the sim card and phone that others are getting” (17 year old 
male) 
“And maybe the cell phone messaging……the one with the phone. But I 
don’t have a cell phone so maybe that won’t be ok…. I don’t know, 





The study a rural clinic in Kenya was to investigate if mobile phone technologies 
improve adherence to ART in a resource-limited setting through a randomized 
controlled trial (Pop-Eleches et al 2011). The researchers found improved 
adherence with the use of the sms reminders. This technology may eventually 
benefit adolescents struggling with adherence even in resource limited settings 
where there is access to cellular phone networks as an adherence intervention. 
The question is on how effective if mobile phone technologies are implement on a 
large scale. The adolescents in this study want them and specifically to address 
their adherence challenges. 
4.3.2.3d. Size of pills  
The size of the pills also emerged as a significant subcategory with some 
adolescents specifically mentioning that their tablets are big as well as advocating 
for the small tablets. These were some of the thoughts expressed by the 
adolescents: 
 
“Maybe if i take like that tablets that you only take at night, the atripla tablet. 
Maybe i won’t forget that one” (18 year old female) 
 
“You know my alluvia tablets are big. I don’t like those tablets...and then 
every (stressing the word) day i have to take them” (18 year old female) 
 
“They are big..” (14 year old female) 
 
“Small little tablets that are sweet” (14 year old female) 
 
(Maggiolo et al (2002:371) investigated factors associated with adherence and 
also found the size of pills to be a factor as it is the case in this study. There were 
adolescents in this study with poor adherence who did not like the fact that their 
pills were big. The size, number, taste of pills as well as doing times and side 




(Stone et al 2004:808; Murphy et al 2003:253; Murphy et al 2001:36).  
4.3.2.3e. Number of pills to take  
This subcategory emerged from adolescents sharing their experience that they 
take many tablets especially those with poor adherence. Less number of tablets 
was also a recommendation to the clinic as what the facility could do for the 
adolescents in order to improve adherence. This was investigated as early as in 
2002 when Maggiolo et al (2002:375) showed that simpler regimens with a lower 
number of pills and doses may help patients’ compliance to therapy. 
 
“..... (pause). I don’t know. Maybe give me a few tablets (14 year old 
female) 
 
“I used to take a few tablets, now I take too many and my stomach hurts all 
the time” (19 year old female) 
 
“..(looking down) ya, I know. Maybe a few tablets then. Or just 1…..I don’t 
know. Something!” (19 year old female) 
 
“Well,….(sad), maybe if there was a time that I could take a break. Just stop 
them and rest. Maybe it would help” (19 year old female) 
 
Number of pills to take: Literature control 
The number of tablets or pill burden may be a perception which just needs to be 
dealt with for some adolescents. Pill burden is known to be an adherence 
hindrance. This is in contrast to an adolescent in this study with good adherence 
who was taking a total of 6 tablets per dose and yet maintained good adherence. 
While acknowledging that the pill burden was high, there was however 
determination to continue knowing that there were not too many options available: 
 





There are various medication issues which have been implicated in literature to 
affect adherence including side effects, pill burden, size, taste, food restrictions as 
well as dosing times (Maggiolo et al 2002:371). Maggiolo et al showed that 
younger age, high number of pills, high frequency of doses and longer time on 
ART were predictors of non-adherent behaviour.  A low pill burden is associated 
with improved adherence while both physical and psychological medication-related 
adverse effects are associated with poorer adherence (Murphy et al 2003:253; 
Murphy et al 2001:36). This is the picture shown in this study and the adolescents 
in this study were advocating for a low pill burden as what would enhance their 
adherence. A low pill burden, with at most twice daily dosing, fewer adverse 
events have been shown to have the greatest impact on patients’ ability to adhere 
to ART (Stone, Jordan, Miller & Pilon 2004:808). 
 
On the contrary, the early studies have actually revealed that a low pill burden and 
improved dose frequency may not necessarily promote adherence (Paterson et al 
1998; Eldred, Wu, Chaisson & Moore 1998). These studies implicated other 
factors as opposed to pill burden or dosing frequency and this could explain the 
scenario of the adolescent taking 6 tablets per dose yet maintain adherence. 
 
4.3.2.3f. Failing to commit to lifelong treatment 
This subcategory reveals adolescents who were failing to commit to the fact that 
ART was a lifelong treatment and hence they had moments in their life where they 
have not seen the need to continue taking their ART. It almost seemed that with 
some of the adolescents they failed to understand or appreciate the fact that 
sometimes they are the only ones in a family or amongst a group of friends who 
have to take ART. 
 
“...I mean exactly that. My mum doesn’t have to take them, no one has to 





“I know why i take them! I said why me! (stressing the ‘me’) (18 year old 
female) 
 
“Why do i have to take them anyway...” (14 year old female) 
 
“...find a cure...(laughing)” (18 year old female on what the government 
should do for her to improve adherence) 
 
“Aah, I mean it’s ok that there are ARVs to help when I am sick but then it 
also means that I have to continue with them for the eh….the rest of my life” 
(16 year old male) 
 
“My friend is ok, he doesn’t take them and I have to take them, eish” (16 
years old male). 
 
“Well,….(sad), maybe if there was a time that I could take a break. Just stop 
them and rest. Maybe it would help” (19 year old female) 
 
“I don’t know….(smiling). Maybe just don’t give me the tablets” (19 year old 
female) 
 
Failing to commit to lifelong treatment: Literature control  
Murphy et al (2001:36) showed that the longer the duration the adolescent has 
been taking ART the poorer the adherence. The minimum duration that adolescent 
was on ART in this study was 4 years and the maximum 9 years. This shows that 
adolescent interviewed in this study had a long experience with ART and those 
failing to realise or commit to a lifelong treatment were not doing well with 
adherence.  One of the early assessments that needs to be done before initiating 
ART as per many HIV guidelines is a discussion of patient readiness for what is 





4.3.2.4 Theme 4: Having a regular doctor (my own doctor) 
Having a regular doctor emerged from the question of what the clinic can do for 
the adolescents to improve or maintain good adherence. Having a regular doctor 
or medical provider means that even in a clinic setting with many doctors, a 
specific doctor should be assigned to specific patients to follow up. This is 
currently not the status quo at BBCCCOE. The point of discussion in this study 
was on what the clinic or government could do for the adolescent in order to 
improve adherence and the following was mentioned: 
 
“There are many doctors here at the clinic and they are always 
changing.....I want my own doctor....(laughing)” (18 year old female). 
 
While this adolescent may not have thought much about the need of a regular 
health care provider, there were some studies which have demonstrated this as a 
facilitator of adherence. Having a consistent health care provider can actually 
emerge as an adherence promoting strategy. Radcliffe, Tanney and Rudy 
(2006:111) studied post-traumatic stress and adherence to medical treatment 
among youth living with HIV and they showed that maintaining regular follow-up 
care and treatment with a specific provider was associated with increased 
adherence. In another study, with a qualitative design on understanding the 
facilitators and barriers of antiretroviral adherence in Peru, a relationship with a 
specific medical provider seem to promote adherence (Curioso, Kepka, Cabello, 
Seguras &Kurth 2010:6). These studies and the findings of this study show that 
maintain a regular health care provider may promote adherence in adolescents. 
 
4.3.2.5 Theme 5: Psychosocial-emotional needs 
This theme explains the implications of loss of a loved one especially a parent on 
adherence. Participants who lost a parent were not doing well on adherence to 
ART implying the lack of psychosocial-emotional support amongst adolescents 





TABLE 4.4  THEME 5: PSCHOSOCIAL-EMOTIONAL NEEDS 
NO THEME CATEGORIES SUBCATEGORIES 
5 Psychosocial-
emotional needs 




Williams et al (2006:e1745) found some factors associated with at least marginally 
significant increases in non-adherence to be occurrence of recent stressful life 
events, repeating in school and diagnosis of depression or anxiety. Clearly in this 
study a difficult experience as well as no family support or death of parents was 
expressed by those with poor adherence. There may be an element of 
bereavement or even depression in these settings reported in this study. The 
following were some of the expressions by the participants in this study: 
 
“Ever since my parents died, my grandmother has had to take care of me. I 
have a sister who also helps, but my grandmother really helped” (18 year old 
female). 
 
“Yes she does help me, she reminds me” (18 year old female referring to 
sister) 
 
“They died” (16 year old male, referring to parents) 
 
“They died… (no eye contact)….(pause). I stay with my grandmother and 
grandfather and my sister. My auntie is at the cattle post” (19 year old female 
 
In their study Murphy et al (2009:1102) found depression to be a factor associated 
with adherence and 49.4% of the participants were depressed as assessed by the 
Center for Epidemiologic Depression Scale. A meta-analysis also showed similar 




interventions aimed at reducing depressive symptom severity were recommended 
(Gonzalez, Batchelder, Psaros & Safren 2011).  
 
Other factors that may affect adherence include lifestyle factors such as 
homelessness, substance abuse, lack of education and mental illness (Chesney 
2000:S173). Such factors did not come up in this study but should also be 
explored when faced with an adolescent with poor adherence. 
 
 Innovative ideas to maintain adherence: Keeping an extra supply of ART 
These emerged from an adolescent's response to a question on suggestions to 
help friends who are struggling with adherence. They acknowledged that it was 
very easy to forget taking ART and their suggestions included   
 
“I now have a trick, I take my medicines to school. So I always keep some 
tablets in my school bag (18 year old female). 
 
“I know sometimes I forget but I always take them when I remember” 
(17year old male) 
 
“Make sure to always take your medicines. If you forget them then take 
immediately you remember” (15 year old male) 
 
4.4 THE EXPERIENCE OF FIELDWORK BY THE RESEARCHER 
The opportunity to conduct qualitative research has been rewarding and a learning 
curve for the researcher. Adolescents form a significant proportion of the 
BBCCCOE and the majority of the adherence challenges at the clinic are found in 
adolescents. Having worked with the clinic for more than 3 years, the researcher 
wanted to contribute to solutions of how to best deal with adolescents on ART with 
adherence challenges. This prompted the researcher into a study to understand 





Observational notes were taken during the interviews as the researcher watched 
and listened to the participants. Observational notes describe the events 
experienced through watching and listening. Personal notes were also taken which 
are reflections of the reactions and experiences of the researcher (de Vos 
2005:33). A connection was made with many of the adolescents and their 
reactions matched their stories. Hope was not all lost as I watched these 
adolescents tell their stories. Clearly most of them were struggling but one could 
see the determination in some.  
 
This research project also gave the researcher a learning opportunity with the 
adolescents at the BBCCCOE to understand why some adolescents behaved the 
way they do while on ART. The challenge with adolescents has always been why 
sometimes there is no behaviour change related to adherence even if after 
undergoing counselling. This resistance to behaviour change sometimes even 
occurs in situations where the adolescents have succumbed to ill-health with 
opportunistic infections as a result of poor adherence.  
 
The group was diverse and really shared their experiences while taking their ART 
with the researcher. Diversity of the adolescents was seen through the age range, 
the duration of their ART as well as the different family environments they all came 
from. Some may have found it difficult to share the factors influencing adherence 
to retroviral drugs with the researcher.   
 
In order to collect adequate and relevant information, the researcher had to build a 
trusting relationship with the adolescents who are HIV positive and are on 
antiretroviral drugs. First contact was made with the adolescents coming for their 
routine follow ups at the clinic work where the researcher is a consulting medical 
doctor. The adolescents were approached and the studies explained to them and 
asked if they would be interested. At all times the adolescents were given a choice 
to participate or not to participate, coercion was avoided at all costs. Those who 




assenting process. Most adolescents at the BBCCCOE do not come to the clinic 
anymore but no separate appointment was given. The potential study participants 
still had to come on their next routine visit to the clinic. These two contacts gave 
ample time for the study participants and parents/caregivers to decide whether to 
participate or not in the study. The BBCCCOE also provided a safe environment 
for the study participants because it is the same place for their routine follow ups 
where the interviews were conducted. 
 
Adolescents with adherence challenges have complex family and social settings 
and they would have undergone several individual or family counselling sessions 
at the clinic. Participating in a study on ART adherence factors meant that they 
may be discussing the same issues they discussed during counselling sessions. 
Particular attention was paid to adolescents with unacceptable adherence and 
reassurance was given and the purpose of the study explained. More time was 
taken with these adolescents even prior to consenting to ensure they are 
comfortable with the study. 
 
4.5 CONCLUSION 
The in-depth individual interviews conducted with 8 adolescents at the BBCCCOE 
revealed themes that facilitate adherence as well as barriers to adherence. These 
adolescents had been on ART for periods ranging from 4 to 9 years and therefore 
they provided reach experiences with their ART over the years. Themes that 
emerged from this study were related to knowledge and positive beliefs about 
ART; the need for support which can be from family, friends or society; a difficult 
treatment because it is life-long treatment as well as the type of medication; having 
a regular doctor as well as psychosocial-emotional needs which are related to 
stressful life situations.  
 
Chapter 5 will conclude the study as well as discuss limitations and make 











This chapter presents the conclusions, limitations and recommendations of this 
study. The study sought to describe the factors that influence adherence to ART 
among adolescents who contracted HIV through vertical transmission, attending 
the BBCCCOE. The knowledge of such factors would assist in ensuring that 
programmes for adolescents include specific measures to improve adherence to 
ART treatment in Botswana.  
 
5.2 RESEACH DESIGN AND METHOD  
The study was non-experimental and qualitative in nature with a descriptive 
phenomenology approach. Qualitative approach was used to develop a rich 
understanding of the phenomenon, adherence to ART among adolescents as it 
exists in the real world and as it is constructed by individuals within the context of 
that world (Polit & Beck 2006:212). 
 
Most adolescents acquire HIV through mother to child transmission, high-risk 
behaviours such as unprotected sex or through infected injection needles. A 
limited but increasing number of HIV-positive adolescents are long-term survivors 
of HIV infection acquired through vertical transmission. Such adolescents have 
been on ART for a longer time than that of adolescents infected later in life hence 
the focus on them as study population. A non-probability sampling purposive 
method was used to select study participants who  have experienced long-term 
ART and were likely to provide information about the phenomenon (adherence to 
ART) under investigation (Burns & Grove 2005:352). Adolescents who participated 
in the study had been on ART for a period of up to nine years.  
 
Adolescents with poor adherence and those with good adherence were included in 




(EMR) which documents adherence at every visit. The sample size was not 
specified, the principle of saturation of data was adhered to.  
 
The interviews were conducted in a private consultation room; giving study 
participants privacy to share their experiences. They were conducted in English by 
the researcher. The participants were assured of confidentiality and anonymity 
The consent to participate in the study was confirmed before the commencement 
of the interviews. With the permission of the participants, all the interviews were 
audio-recorded and notes were taken during the interview in order to capture all 
the information and/or non-verbal observations. Each interview session took about 
30 minutes. A total of eight (8) adolescents were interviewed. 
 
Thematic analysis of the data was according to Van Manen (1990) cited in Polit & 
Beck (2008:519) using the holistic and the selective approaches. Themes were 
identified and they reflected a description of factors influencing adherence in 
adolescents living with HIV on ART at a referral facility in Botswana. 
 
5.3  SUMMARY AND INTERPRETATIONS OF THE RESEARCH RESULTS 
Factors influencing adherence to ART amongst adolescents attending the 
BBCCCOE were identified in the different themes that emerged during the study. 
Themes that emerged from this study were related to knowledge and positive 
beliefs about ART; the need for support which can be from family, friends or 
society; a difficult treatment because it is life-long treatment as well as the type of 
medication; having a regular doctor as well as psychosocial-emotional needs 
which are related to stressful life situations.  
 
5.3.1 Knowledge and positive beliefs about ART 
Knowledge and positive beliefs about ART promote adherence to ART. The 
participants demonstrated substantial knowledge about the benefits of ART but the 
knowledge was not consistent with adherence levels. In this study, an adolescent 




a difficult experience was doing well with adherence. Even though it was difficult, 
but appreciating and acknowledging the difficulties seem to give an edge on these 
adolescents to go through the difficult experience.  This was evident from the 
expressions which showed their belief in the benefits of ART. 
 
5.3.2 Need for support   
Adolescents in this study demonstrated the need for support and this was in the 
form of family support, support from friends as well as support from the society. A 
good family support structure promoted adherence as revealed by adolescents 
with good adherence to ART who reported getting help from family members who 
reminded them to take their medication. Not only does support from family and 
friends enhance adherence, it also promotes disclosure of the HIV status.    
 
5.3.3 Difficult treatment 
It was clear from the experiences of adolescents that committing to a lifelong 
treatment was not easy especially when it has to happen at an early age. 
Medication related factors such as the side-effects of ART, interference with daily 
activities/routine, size of pills, number of pills and many doses. The common side 
effects mentioned were vomiting and stomach cramps. The ideal ART regimen 
would be with minimum number of pills taken preferably once a day without 
interference of daily routines, small pills and few side-effects.  
 
Forgetting to take ART was a common experience expressed by adolescents who 
had poor adherence. Adolescents with good adherence who admit to forgetting to 
take their ART usually have corrective measures such as taking immediately one 
remembers. Being forgetful in this study was addressed by the use of electronic 
gadgets as well as being reminded by family members. 
 
5.3.4 Having a regular doctor (my own doctor) 
Maintaining a regular contact with specific health care workers especially a regular 




finding since it has already been reported that a relationship with a specific 
medical provider promotes adherence (Curioso et al 2010:6). 
 
5.3.5 Psychosocial-emotional needs 
Stressful life situations such as the loss of a parent may have a negative impact on 
adherence to ART in adolescents living with HIV. This was evident in adolescents 
who had lost one or both parents. Depression, anxiety as well as bereavement 
may play a role in influencing adherence in adolescents living with HIV. 
Depression has been reported in literature to affect adherence implying that an 
assessment of baseline depression would be important before initiation of ART 
(Murphy et al 2009:1102).   
 
Fear of stigma and discrimination was evident in some of the adolescents who 
preferred to keep their HIV status their ‘secret’ especially to school teachers and 
friends.  
 
Before initiating ART on children and adolescents it is important to make an 
assessment of the family situation to see if a support network exists. Disclosure of 
HIV status was an important element when considering the circles of support as 
there was need for disclosure if help was sort. This follows the findings in many 
studies that demonstrated the benefits of disclosure as reported in a Botswana 
study as well by Phalade et al (2009). Phalade et al investigated challenges faced 
by adolescents living with HIV in Botswana and found that HIV disclosure among 
other factors was associated with adherence. This means that disclosure and 
continued education of the adolescent about HIV and ART could impart the 
knowledge needed to sustain adherence. Obviously the fear of stigma and 
discrimination made it difficult for some of the adolescents to disclose their HIV 
status especially to school teachers and friends for fear of stigmatisation and 
possible discrimination. 
 




homelessness, substance abuse, lack of education and mental illness (Chesney 
2000:S173). Such factors did not come up in this study but should also be 
explored when faced with an adolescent with poor adherence. 
 
5.4 CONCLUSION 
The themes that emerged from this study (knowledge and positive beliefs about 
ART, need for support, difficult treatment, having a regular doctor, psychosocial-
emotional needs) show that there is need for a baseline assessment of 
adolescents before initiation of ART. The baseline assessments would include 
psychological (depression screening) as well family support; knowledge of HIV 
and ART including disclosure. Such assessments would then be periodically 
conducted at every contact. Where possible a regular doctor as well as a 
simplified ART regimen would be recommended.  
  
5.5 RECOMMENDATIONS 
The recommendations emanating from the study are based on practice, education 
and further research as it pertains to adolescents and adherence to ART. The 
following outline recommendations made based on the experiences shared by 
adolescents in this study. The study participants also had an opportunity to share 
what they thought could be done for them and is also incorporated in the 
recommendations below.  
 
5.5.1 Recommendations with regard to practice of health professionals 
The findings from this study provide valuable information to facilities managing 
adolescents living with HIV. Before initiating ART on children and adolescents it is 
important to make an assessment of the  level of knowledge about HIV and ART, 
the family situation, beliefs about and attitude HIV and ART and the motivation ( or 
lack thereof ) for commitment to ART.  Disclosure of HIV status was an important 
element when considering the circles of support as there is need for disclosure. 
The implication for health professionals’ practice is continued education of the 






All facilities dealing with adolescents should have specialized staff that deal with 
adolescents and understand their needs as well as how to communicate with 
them. Given the findings of this study, there is need for a friendly, supportive and 
non-judgmental attitude of all health care providers as well as convenient 
appointment scheduling and confidentiality.  
 
Involvement of adolescents in their own care has shown benefits in this study. The 
adolescents made suggestions of how the government and health care providers 
could help improve their adherence to ART. They also made good suggestions of 
how they can help each other maintain adherence. Their suggestions included the 
use of electronic reminders, taking treatment to school and taking treatment as 
soon as it remembered in cases of forgetfulness. They also challenged the 
medical profession to find a cure for HIV 
 
5.5.2 Recommendations regarding the education of health care 
professionals 
A facility that takes care of adolescents should have standard operating 
procedures (SOPs) that clearly outline all areas that should be explored in an 
adolescent prior to initiating ART. The SOPs would outline what is required at 
screening, initiation as well as follow up of adolescents living with HIV. 
 
Facilities managing adolescents living with HIV should have also have specially 
trained providers who follow up these adolescents. Continuity of care with constant 
providers may also build trust by the adolescents thereby making it easier to 
manage them.  
 
 
5.5.3 Recommendation regarding further research 




the wellbeing of people living with HIV as well as adherence to ART. While studies 
have documented factors influencing adherence to ART in different settings, there 
is need to investigate a package that can be implemented to assist people living 
with HIV who are on ART. Adolescents are an important but yet challenging group 
that needs to be further researched. Interventions that work would most likely be 
location specific hence these will need to be further tested in each locality before 
use. 
 
5.6 LIMITATIONS OF THE STUDY  
The limitations of this study were mainly related to the research setting and the 
researcher. This study was conducted at a referral facility in Botswana. The profile 
of patients at this centre is mainly complicated cases from a clinical as well as 
psychological end. This means that patients with adherence challenges may be 
more complicated and at the same time patients with acceptable adherence may 
have been managed well enough to reach acceptable adherence levels. This 
facility would not be representative of other facilities in peripheral clinics, district 
hospitals as well as primary hospitals. The participants in this study may have 
demonstrated biased information which may not apply to other participants in other 
facilities. 
 
The setting of the study is also a research facility which means that some of these 
participants may have participated in prior studies related to adherence and may 
have given biased information. It was however assumed that the participants 
would be honest and it was ensured that all participants in this study were not 
concurrently participating in other studies at the time of the interviews. 
 
5.7 CONCLUDING REMARKS 
This study investigated factors influencing adherence to ART among adolescents 
living with HIV at the Botswana-Baylor Children’s Clinical Centre of Excellence. 
The adherence factors identified in this study were related to the knowledge and 




difficult treatment related to lifelong treatment and type of medication, having a 
regular doctor and psychosocial-emotional needs. Adolescents require support 
while taking simplified ART regimens after an assessment of their psychological 
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ANNEXURE 2: MOH APPLICATION FOR APPROVAL OF HUMAN RESEARCH     
 
         Ministry of Health   
     
  Republic of Botswana 
Application for Approval of Human Research 
 
Section A: Instructions 
1. For research/academic institutions or PHD students attach: 
14 copies of the Research Application form 
4 copies of the following: 
i. Study proposal. 
ii.  Consent/authorization form or a request for waiver of consent/authorization- Setswana, 
English and back translation where applicable. 
iii. Questionnaires to be used. Setswana, English and back translation where applicable. 
iv. Curriculum vitae/ resume of each member of the Research team 
v. Approval letter from other  IRBs 
vi. Grant approval letter  
vii. Any other supporting materials i.e. recruitment scripts, brochures, flyers etc 
      2. For undergraduates and graduates attach one copy of the above listed items/ documents.  
 
Section B: Application Details 
 
1. Study Title: (Include Version number and date) 
FACTORS INFLUENCING ADHERENCE TO ANTIRETROVIRAL THERPAY IN 
ADOLESCENTS AT BOTSWANA-BAYLOR CHILDREN’S CLINICAL CENTRE OF 
EXCELLENCE- A QUALITATIVE STUDY 
2. Date of submission: 16/12/2010 
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ii. Public Health              (X) 
iii. Clinical Research       (  ) 
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ANNEXURE 5: INFORMED CONSENT FORM: ENGLISH  
 
Informed Consent Form 
FACTORS INFLUENCING ADHERENCE TO ANTIRETROVIRAL THERAPY IN 
ADOLESCENTS AT BOTSWANA-BAYLOR CHILDREN’S CLINICAL CENTRE 
OF EXCELLENCE- A QUALITATIVE STUDY. 
GUARDIAN CONSENT FORM 
My name is Dr Tafireyi Marukutira and I am a Masters of Public Health (MPH) 
student at the University of South Africa (UNISA). I am currently working for the 
Botswana-Baylor Children’s Clinical Centre of Excellence, a partnership between 
Baylor College of Medicine and the Government of Botswana. I am doing a study 
to identify the factors that are associated adherence to ART among children aged 
10 to 19 years of age. 
The study has been approved by UNISA, the Ministry of Health of Botswana and I 
have been given permission by Baylor Clinic to do the study. 
I would like to interview your child to discuss issues related to how he/she takes 
her medicine. A tape-recorder will be used during the interview. I also intend to get 
some information from the Electronic Medical (EMR) system at Baylor Clinic to 
assess his/her adherence. This information will be used to help health care 
workers to understand better why adolescents have poor or good adherence. It will 
help your child and other children once we understand the underlying factors. 
The information gathered during this study will be kept completely confidential. 
Names and any other personal identifiers will not be published or made accessible 
to unauthorized persons. Your child does not have to answer any questions that 
he/she does not want to answer and she/he may discontinue answering the 
questionnaire, at any time she/he may choose. Your child will not be compelled to 
answer any questions they wish not to answer.  
Neither you nor your child will be subjected to any physical risk of injury, pain or 
trauma and every effort has been made to ensure that any emotional stress or 
disturbance to study participants is minimized. Your child has access to a 
professional counsellor at the centre if needed. 
The interview will take about 30 minutes to complete. 
If you agree for your child to participate, please indicate this by signing in the 
space below: 
 
_________________________         ____________________        _________ 
Name of Guardian     Signature            Date 
 
_____________________                  __________________           ___________ 








ANNEXURE 6: INFORMED CONSENT FORM: SETSWANA  
 
 
SETSWANA INFORMED CONSENT 
FACTORS INFLUENCING ADHERENCE TO ANTIRETROVIRAL THERAPY IN 
ADOLESCENTS AT BOTSWANA-BAYLOR CHILDREN’S CLINICAL CENTRE 
OF EXCELLENCE- A QUALITATIVE STUDY. 
 
Tletla ya motsadi 
Leina lame ke ngaka Tafireyi Marukutira, ke moithuti kwa Mmadikolo ko Afrika 
Borwa(UNISA), mme ke bereka mo kokelong ya Botswana Baylor COE, e e leng 
bokopano gareng ga Baylor college of Medicine le goromente wa Botswana.Ke 
dira ditsheka-tsheko/patlisiso ka mabaka aa amangwang le go tsaya/nwa  sentle 
kgotsa go sa ditsaya/nwa sentle diritibatsi mo baneng ba ba dingwaga tse di 
lesome go yak o go lesome le boferabongwe(10-19) 
 
Patlisiso ee dumeletswe ke ba mmadikolo kwa Afrika Borwa (UNISA), le lephata la 
botsogo la Botswana.Godimo ga moo, ke filwe tetla ke ba kokelong ya Baylor go 
simolola tsheka-tsheko. 
 
Ke kopa go botsa bana dipotso mabapi le ka fa ba tsayang/nwang melemo ya 
bone ka teng. Ke tla dirisa tape recorder. Mme gape ke tla lebelela ka fa ba ntseng 
ba dira ka teng mo molemong go tswa mo difaeleng(files) tsa bone tse di 
dirisiwang kwa kokelong ya Baylor. Se se tla thusa gore babereki ba botsogo ba 
tlhaloganye botoka gore ke eng bana ba ba fatlhogang bana a le bothata kgotsa 
ba sena bothata jwa go tsaya/nwa melemo.Go tla thusa gape ngwana wagago le 
babangwe fa re ka tlhaloganya mabaka a. 
 
Sepe se se kgobokantsweng mo tsheka-tshekong e, e tlaa nna sephiri.Maina le 
ditshupetso tsotlhe di tla seke di gatisiwe kgotsa di bonwe ke ope fela yo o sa 
letelelwang. Ngwana wagago ga a patelesege go araba potso epe e a sa batleng 




tse bana ba ka se phuthologing go di bua fa pele ga motsadi, ka jalo re tlaa kopa 
go botsolosa bana ba le nosi.Mme le fa go ntsi jalo ngwana ga a patelediwe go 
araba potso ea sa batleng go e araba, gape o na le tshwanelo ya go kopa gore 
motsadi a nne teng fa potsoloso e ntse e tsweletse. 
 
Tsheka-tsheko e, ga e na go baya ope, a ke motsadi kgotsa ngwana mo 
diphatseng dipe. Go ne ga tsewa kelelelo e kgolo go netefatsa gore go kgoberega 
maikutlo ga motsaa karolo mo tsheka-tshekong e go ko tlase kana ga 
goyo.Ngwana wag ago wa letelesega kgotsa o gololesegile go bona ba ba 
sedilang maikutlo mo kokelwaneng ya Baylor fa go tlhokega.Potsoloso e e tlaa 
tsaya magareng ga metsotso ee masome mararo. 
 
Fa o dumalana gore ngwana wag ago o ka tsaa karolo mo patisisong e, supa ka 
go baya monwana fa: 
 
 
………………………                                  ………………….       …………….. 
Leina la Motsadi                                       Baya   Monwana                Letsatsi 
 
……………………….                                   ………………       ……………… 



















ANNEXURE 7: ASSENT FORM: ENGLISH 
 
Assent form 
FACTORS INFLUENCING ADHERENCE TO ANTIRETROVIRAL THERAPY IN 
ADOLESCENTS AT BOTSWANA-BAYLOR CHILDREN’S CLINICAL CENTRE 
OF EXCELLENCE- A QUALITATIVE STUDY. 
ASSENT FORM 
My name is Dr Tafireyi Marukutira and I am a University of South Africa (UNISA) 
Masters of Public Health (MPH) student. I am currently working for the Botswana-
Baylor Children’s Clinical Centre of Excellence, a partnership between Baylor 
College of Medicine and the Government of Botswana. I am doing a study to find 
out factors that are associated with adherence to ART for children aged 10 to 19 
years of age. 
The study has been approved by UNISA and also by the Ministry of Health of 
Botswana. I have also sort permission from Baylor Clinic to do the study. 
I would like to you to answer some questions related to how you take your 
medicine. A taper-recorder will be used during the interview. I will also get some 
information from the Electronic Medical (EMR) system at Baylor Clinic to assess 
your adherence as well. This information will be used to help health care workers 
to understand better why adolescents have poor or good adherence. It will help 
you and other children once we understand the underlying factors for good and 
poor adherence. 
The information gathered during this study will be kept completely confidential. 
Names and any other personal identifiers will not be published or made accessible 
to unauthorized persons. You do not have to answer any questions that you do not 
want to answer and you may discontinue at any time you may choose.  
You will not be subjected to any physical risk of injury, pain or trauma and every 
effort has been made to ensure that any emotional stress or disturbance to study 
participants is minimized. You will have access to a professional counsellor at the 
centre if needed during the process. 
The interview should take about 30 minutes to complete. 
If you agree for to participate, please indicate this by signing in the space below: 
_____________________              _______________________           ________ 
Name of Adolescent    Signature  Date 
__________________                 _______________________            _________ 













ANNEXURE 8: ASSENT FORM: SETSWANA 
 
SETSWANA Assent Form 
FACTORS INFLUENCING ADHERENCE TO ANTIRETROVIRAL THERAPY IN 
ADOLESCENTS AT BOTSWANA-BAYLOR CHILDREN’S CLINICAL CENTRE 
OF EXCELLENCE- A QUALITATIVE STUDY. 
 
Leina lame ke ngaka Tafireyi Marukutira, ke moithuti kwa Mmadikolo ko Afrika 
Borwa(UNISA), mme ke bereka mo kokelong ya Botswana Baylor COE, e e leng 
bokopano gareng ga Baylor college of Medicine le goromente wa Botswana.Ke 
dira ditsheka-tsheko/patlisiso ka mabaka aa amangwang le go tsaya/nwa  sentle 
kgotsa go sa ditsaya/nwa sentle diritibatsi mo baneng ba ba dingwaga tse di 
lesome go yak o go lesome le boferabongwe(10-19). 
Patlisiso ee dumeletswe ke ba mmadikolo kwa Afrika Borwa (UNISA), le lephata la 
botsogo la Botswana.Godimo ga moo, ke filwe tetla ke ba kokelong ya Baylor go 
simolola tsheka-tsheko. 
 
Ke kopa go go botsa dipotso mabapi le go tsaa/nwa melemo ga gago. Ke tla dirisa 
tape recorder. Ke  tsile go lebele la mo faeleng ya gago ka fa o ntseng o dira/nwa 
melemo ka teng.Se se tsile go thusa badiri ba botsogo go tlhaloganya  botuka 
gore ke eng bana ba ba fatlhogang ba sadire/nwa kgotsa ba dira/nwa diritibatsi . 
Se se tlaa thusa wena le babangwe fa re ka itse mabaka a. 
Sepe se se kgobokantsweng mo tsheka-tshekong e, e tlaa nna sephiri.Maina le 
ditshupetso tsotlhe di tla seke di gatisiwe kgotsa di bonwe ke ope fela yo o sa 
letelelwang.Ga o patelesege go araba potso epe e o sa batleng go e araba gape o 
na le Tshwanelo ya go emisa tsheka-tsheko e nako ngwe le ngwe fa o batla.O tla 
bo o botsolotswa ntleng le motlhokomedi wagago, mme o na le tshwanelo ya go 
kopa gore a nne teng fa o botsolotswa. 
 
Tsheka-tsheko e, ga e na go baya mo diphatseng dipe. Go ne ga tsewa kelelelo e 




tshekong e go ko tlase kana ga goyo.O gololesegile go bona ba ba sedilang 
maikutlo mo kokelwaneng ya Baylor fa go tlhokega.Potsoloso e e tlaa tsaya 
magareng ga metsotso ee masome mararo. 
 
___________________              ____________________       _____________ 
Leina la motsaa karolo                     Baya  Monwana                              letsatsi 
____________________            ___________________         _____________ 






































ANNEXURE 9: INTERVIEW GUIDE  
 
   
Thank you for taking time to meet with me today. My name is Tafireyi Marukutira 
and I would like to talk to you about your experiences taking ART.  The interview 
should take about 30 minutes.  
  
I will be tape recording the interview because I do not want to miss any of your 
important information and also because I cannot write fast enough to get 
everything you say. I will also be writing some notes. Please be sure to speak up 
because we are on tape and we do not want to miss anything 
  
All your responses will be kept confidential; they will only be shared with the 
research team members. You do not have to talk about anything you don’t want to 
and you may decide to end the interview at any time. 
Are there any questions?  
  
You are willing to take part in this interview and you have signed the assent form 
and your parents/ guardians have signed the consent form.  
  
QUESTIONS FOR THE COMPLIANT CLIENT 
1.    For how long have you been on ART?   
(The response to this question should be compared to the duration on the patient’s 
record and if the client meets the criteria of ‘must have been taking ART for at 
least 1 year’, then continue with the interview as follows 
Our records show that you have been taking you treatment correctly and 
consistently as per doctor’s prescription. Well done. 
2.    How have you experienced taking ART for such a long time? 
3.    What motivates you to continue taking your ART so consistently? 
What do you think helps you to take your ART correctly?  
4.    What advice would you give to a friend who is struggling with 




5.    What would you ask from the clinic or the government to help you 
maintain your levels of adherence to your medicines? 
  
QUESTIONS FOR THE  NON- COMPLIANT CLIENT 
1      For how long have you been on ART?   
(The response to this question should be compared to the duration on the patient’s 
record and if the client meets the criteria of ‘must have been taking ART for at 
least 1 year’, then continue with the interview as follows 
  
According to our records, you have not been taking your ART correctly and 
consistently as per doctor’s prescription.  
2. How have you experienced taking ART for such a long time? 
3. Why don’t take your ART according to the prescription? 
4.    What do you think can be done to help you take your medicines 
correctly? 
4. What would you ask from the clinic or the government to help you 
take your medicines 
Is there anything you would like to add?  
I will be analyzing the information you and others gave. I will be happy to share 
with you the report.   













































RE: REQUEST FOR AVAILABILITY DURING IN-DEPTH INTERVIEWS 
 
A request is hereby submitted to you asking for your availability during the conduct of in-
depth interviews for my research project. The research is a qualitative research on factors 
influencing adherence in adolescents and in-depth interviews will be conducted. This is a 
minimal risk research but in the event of psychological instability during the conduct of 
the interviews, these research participants may be referred to you for further management. 
 




DR TAFIREYI MARUKUTIRA 
 
BOTSWANA BAYLOR CHILDREN’S CLINICAL 
CENTRE OF EXCELLENCE 
Princess Marina Hospital  1863 Hospital Way  P/Bag BR 129 
Gaborone  Botswana 








































ANNEXURE 13 : TRANSCRIPT 
 
AN EXAMPLE OF TRANSCRIPT 
TRANSCRIPTIONS 1 
18 yr old female 
AHDERENCE CLASS: GOOD/ACCEPTABLE ADHERENCE) 
Interviewer: Thank you for taking time to meet with me today. Good morning. 
Interviewee: Morning 
Interviewer: How are you today? 
Interviewee: I am ok. 
Interviewer: My name is Tafireyi Marukutira and I would like to talk to you about 
your experiences taking ART.  The interview should take about 30 minutes.  
Interviewee: Ok 
Interviewer: I will be tape recording the interview because I do not want to miss 
any of your important information and also because I cannot write fast enough to 
get everything you say. I will also be writing some notes. Please be sure to speak 
up because we are on tape and we do not want to miss anything. Is that ok with 
you? 
Interviewee: That’s fine 
Interviewer: All your responses will be kept confidential. This information will only 
be shared with the research team members. Is that ok? 
Interviewee: Yes 
Interviewer: And let me also tell that you do not have to talk about anything you 




any questions so far? 
Interviewee: No 
Interviewer: Let me also remind that you agreed to participate in this study and you 
signed the assent form. However you are free to stop me from continuing at any 
time. And your caregiver signed for you to participate in this study. But all the 
same its still up to you. Is that ok with you?  
Interviewee: Yes 
Interviewer: Can we continue? 
Interviewee: Yes 
Interviewer: How long have you been on ART? 
Interviewee: Umm, since 2004. 
Interviewer; And how old are you now? 
Interviewee: I was born in 1996 
Interviewer: So that makes you 18 years this year? 
Interviewee: Yes 
Interviewer: So that means you were about 8 years when you started you ART? 
Interviewee: ….ummm, yes. 
Interviewer: Your clinic records show that so far you have been doing well with 
your medications, taking them as prescribed. That’s good. 8 years taking your 
ART is a long time and yet you have done well, can you tell me how it has been for 
you over the years? 




Interviewer: I understand that, can you share with me your experiences, how it has 
been like for you so far? 
Interviewee: Ah, I think for me it’s been difficult even though somehow I have 
managed. Ever since my parents died, my grandmother has had to take care of 
me. I have a sister who also helps me but my grandmother has really helped. 
Interviewer: I am sorry to hear about your parents. Did that affect you? 
Interviewee: I was very young then but I still remember. Then it was my 
grandmother that we were staying with. 
Interviewer: How many siblings do you have? 
Interviewee: 1 
Interviewer: And that’s your sister? 
Interviewee: Yes 
Interviewer: And how does your sister help you take meds? 
Interviewee: Yes she does help me, she reminds me. 
Interviewer: What has been the difficult part taking of taking your meds? 
Interviewee: Having to wake up and make sure that I take my tablets before going 
to school. Sometimes I forget especially if my grandmother is not around. 
Interviewer: What do you use to remind you? 
Interviewee: My grandmother helps and I also have an alarm clock. 
Interviewer: So with those two things how do you forget your morning doses? 
Interviewee: Because….ah, my grandmother will wake me up and then even if my 




don’t take them immediately my grandmother tells me then sometimes I forget. 
Interviewer: So even though you sometimes forget to take in the morning, you 
have done well. What helps you to take your medicines correctly? 
Interviewee: I now have a trick, I take my medicines to school. So I always keep 
some tablets in my school bag. 
Interviewer: That’s clever of you. And how do you take them at school? Does 
anyone get to see you when you take them? 
Interviewee: I just take them….ah. No one cares. 
Interviewer: Have you told anyone at school that you take ART? 
Interviewee: My friend and my guidance teacher knows. 
Interviewer: What else helps you take your ART? 
Interviewee: I think there is no cure for HIV and this is all there is….Unless if there 
is something now? 
Interviewer: No, that’s the best treatment so far. So what did you tell yourself what 
about ART? 
Interviewee: Well, I told myself that if I don’t take my tablets I will be sick. 
Interviewer: Have you been sick before because you did not take your meds? 
Interviewee: Yes. 
Interviewer: What happened? 
Interviewee: I don’t remember but I was admitted mo Marina for some days. I 
remember those days I was not taking my ART 




Interviewee: I don’t remember maybe 14? 
Interviewer: And then what happened? 
Interviewee: Then they changed my tablets and after that I always make sure I 
take my tablets. 
Interviewer: How many tablets where you taking before they changed them? 
Interviewee: 4 
Interviewer: And now? 
Interviewee; 6 
Interviewer: That’s a lot? 
Interviewee; Yes but what can I do? 
Interviewee; Well, I guess not much but I should congratulate you for taking that 
number of tablets every day. Is that what you take in the morning only? 
Interviewee: 6 in the morning and another 6 in the evening. 
Interviewer: What advice would you give if your friend was not doing well taking 
ART? 
Interviewee: Ahh, I don’t know. 
ADVISE TO A FRIEND 
Interviewer: If I ask you to talk to someone because you have done well with your 
ART what would you tell them? 
Interviewee: Well, if they don’t take ART they will be sick. Don’t wait until you are 
sick. Like what happened to me. 




Interviewee; And what would you ask the clinic or government to help you maintain 
your adherence?  
Interviewee: Well, I don’t know. There are many doctors here at the clinic and they 
are always changing. 
Interviewer: So you want a few doctors? 
Interviewee: I want my doctor….(laughing) 
Interviewer: And would you ask anything from the government? 
Interviewee: I don’t know. 
Interviewer: Thank you very much for your time. We are finished. Do you have any 
questions? 
Interviewee; No 
Interviewer: Is there anything you would like to add?  
Interviewee: No 
Interviewer: I will be analyzing the information you and others gave. I will be happy 
to share with you the report. Thank you for your time, ke a leboga 
 
